US3260656A - Method and apparatus for electrolytically determining a species in a fluid - Google Patents

Method and apparatus for electrolytically determining a species in a fluid Download PDF

Info

Publication number
US3260656A
US3260656A US226533A US22653362A US3260656A US 3260656 A US3260656 A US 3260656A US 226533 A US226533 A US 226533A US 22653362 A US22653362 A US 22653362A US 3260656 A US3260656 A US 3260656A
Authority
US
United States
Prior art keywords
gas
membrane
cathode
anode
electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US226533A
Inventor
Jr James W Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corning Glass Works
Original Assignee
Corning Glass Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corning Glass Works filed Critical Corning Glass Works
Priority to US226533A priority Critical patent/US3260656A/en
Priority to GB37978/63A priority patent/GB1037627A/en
Application granted granted Critical
Publication of US3260656A publication Critical patent/US3260656A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/403Cells and electrode assemblies
    • G01N27/404Cells with anode, cathode and cell electrolyte on the same side of a permeable membrane which separates them from the sample fluid, e.g. Clark-type oxygen sensors

Definitions

  • fluids as used herein is intended to include gases, liquids, vapors and mixtures thereof.
  • electrochemical devices in the determination of the concentration in fluids of an electrochemically active species (i.e. a substance such as an ion which is capable of being either reduced oroxidized at an electrode), electrochemical devices have been used in which an electrical characteristic of the species is measured and correlated with the concentration.
  • Polarographic devices for example, usually measure a characteristic potential at which such a species is reduced, and a diflusion current proportional to the concentration.
  • An improvement on the basic polarographic apparatus is the well-known Clark apparatus as disclosed in US. Patent No. 2,913,386 issued November 17, 1959.
  • the latter employs a dual electrode structure immersed in an electrolyte and encased at least in part in a membrane which is permeable to a predetermined species, for instance, gaseous oxygen.
  • a predetermined species for instance, gaseous oxygen.
  • the cathode is formed of platinum and is located closely adjacent the membrane; the anode is formed of silversilver chloride; and the electrolyte is an aqueous alkali halide solution.
  • oxygen in a test fluid outside of the membrane permeates the latter and is presumably reduced at the cathode to water in accordance with the overall equation 2H++1/2O2+2 H20 It will be apparent that the Clark device is intended to completely reduce the oxygen permeating the membrane.
  • the current (2e) necessary to effect this reduction is a measure then of the oxygen concentration in the test fluid.
  • this device typically employs the Ag-AgCl anode with a KCl electrolytic solution.
  • the anode reaction is Ag+Cl- AgCl+e
  • H+ is consumed at the cathode, changing the pI-I of the electrolyte in time. For prolonged operation, a buflFer is therefore required.
  • FIG. 1 there is shown graphically a concentration diagram for such devices.
  • the ordinate 20 is the scale from zero of the relative concentration of oxygen, and the abscissa represents distance from the cathode-membrane interface toward a test fluid.
  • the position of the cathode-membrane interface (neglecting any small displacement between the two) is at line 20.
  • Line 22. parallel to the ordinate, then represents the membrane-test fluid interface.
  • the distance between lines 20 and 22 is representative of the membrane thickness.
  • the concentration gradient, represented by the remainder of broken line 24, across the membrane is approximately linear and its slope is an inverse function of the membrane thickness.
  • the distortion of concentration gradient reduces the measurement sensitivity and changes the mass flow rate of oxygen through the membrane to the cathode, making measurement uncertain and even spurious over a period of time.
  • the fluid under measurement is a minute sample to which access is restricted, as in biological cells for example, depletion will continue until all of the oxygen is consumed. Because access to the fluid is restricted by the cell walls which act as barriers, the consumed oxygen cannot readily be renewed; the measurements in a short time become inconclusive. Additionally, even assuming that local depletion layers on the outer membrane surface can be avoided, in order to maintain the gas concentration at the cathode substantially at zero with reasonable current consumption the input flow rate of the oxygen must be controlled. This is usually done by providing a relatively thick membrane which, however, acts to slow the response time of the device to changes in oxygen concentration in the test fluid.
  • the present invention contemplates the provision of improvements in electrochemical analytic devices by virtue of which the sensitivity and response time are enhanced, and which improvements minimize material changes in the concentration of the species in the fluid under measurement during the measurement time.
  • a principal object of the present invention is therefore to prove an improved electrochemical analytical device.
  • an electrochemical device including enclosure means (for an electrolytic medium, at least a portion of the enclosure means being formed of barrier means selectively permeable to a predetermined spaced relation to one another within the enclosure means, means *for impressing -a predetermined potential difterence across the electrode, the electrolytic medium being one from which the elect-ro-active species can be liberated by passage of electrical current between said electrodes, the electrolytic medium bridging the electrodes and being in contact with the barrier means; to provide such a device in which one electrode is adapted to consume said species and the other electrode is adapted to generate said species; to provide such a device in which the cathode is adapted for reduction of said species and the anode is adapted to generate said species; to provide such a device in which the cathode is adapted for reduction of said species and the anode is adapted to generate said species; to provide such a device in which the cathode is adapted for reduction of said species and the anode is adapted to generate said species in dependence upon said reduction,
  • a device including a reference electrode which is in contact with the electrolytic medium and provides a high stability to the potential at the consuming electrode; to provide such a device which does not substantially aifect or deplete the concentration of the electro-active species outside of the enclosure means except (briefly, at all, during transient changes in said concentration) for appreciable time periods and in restricted samples of fluid; and to provide such a device in which the sensitivity and response time to changes in the concentration of electro-active species in the test fluid are markedly improved.
  • Yet other objects of the present invention are to provide an electrical circuit for use with an electrochemical analytic device of the type described; and to provide such an electrical circuit which includes a negative feedback loop for stabilizing the potential between a reference electrode and a consuming electrode.
  • FIG. -1 is a graphical representation of the concentration gradient across the selectively permeable membrane in prior art devices as hereinbef-ore described;
  • FIG. 2 is a diagrammatic cross-sectional view of one embodiment of the present invention.
  • FIG. 3 is a graphical representation of a concentration gradient across a portion of the electrode-membrane structure of the embodiment shown in FIG. 2;.
  • FIG. 4 is a graphical representation of the current-voltage relationship at the electrodes in the structure of FIG. 2;
  • FIG. 5 is a diagrammatic cross-sectional representation of another embodiment of the present invention.
  • FIG. '6 is a diagram of an electrical measuring circuit particularly adapted for use with the electrode structure of FIG. 5.
  • the present invention generally comprises a pair of electrodes electrically coupled through an electrolytic medium of predetermined fixed characteristics.
  • the medium is isolate-d from the test fluid under measurement by barrier means selectively permeable to the electro-active species which is to be detected and measured in the test fluid.
  • a first electrode is adapted to consume the desired electro-active species, while the other electrode is adapted to produce or generate said species in dependence on the consumption activity of the first electrode.
  • electro-active species as used herein is intended to mean any group of identical chemical entities such as ions, molecules, atoms, etc., which are capable of being electrically oxidized or reduced.
  • the species is a gas e.g. oxygen, chlorine or the like, which is dissolved in or mixed with another fluid, rather than referring to concentration, it is perhaps more accurate to refer to the equilibrium partial pressure. This is so because a gas may exhibit different solubilities with respect to difrferent fluids.
  • the equilibrium partial pressure (hereinafter referred to as the tension) of the gas in one fluid may be precisely equal to the tension of the same gas in another fluid, the concentrations of gas with respect to each of the fluids are not necessarily the same.
  • the tension on one side is proportional to the concentration on the other side.
  • FIG. 2 there will be seen one embodiment of the present invention in which there is shown a structure comprising a first electrode or anode 30, a second electrode or cathode 32, an electrolytic medium 34 which electrolytically coupled the anode and cathode, and selectively permeable barrier means, such as membrane 36.
  • Means, such as battery 38, are provided for applying an appropriate potential across the cathode and anode through respective leads 46 and 47.
  • the invention also may include means shown schematically as meter 40, for measuring current flow in the cathode anode circuit.
  • enclosure means 42 which preferably incorporates membrane 36 as a Wall portion thereof.
  • Enclosure means 42 is preferably formed with a substantially hollow chamber 44 interiorly thereof, the chamber having at least one opening to the outside of the enclosure means.
  • Membrane 36 is so disposed as to completely cover the opening in chamber 44.
  • the electrolytic medium i.e. a medium capable of providing both positive and negative ionic charge transport as by ions provided from a disassociatable compound in a polar solvent, or by ions provided by a molten salt or the like
  • an aqueous electrolyte is disposed within the chamber in suflicient quantity to maintain a continuous electrical contract between electrodes.
  • the enclosure means preferably then is formed as a liquid-tight container so that the electrolyte cannot leak out.
  • the electrolyte is preferably selected to be one whose ions require a more negative potential for reduction than does hydrogen and require a more positive potential for oxidation than does water or hydroxyl ion.
  • the dilference between these more negative and positive potentials is generally termed the decomposition voltage of the electrolyte.
  • the walls of chamber 44, other than membrane 36, are preferably made of a material, such as glass, ceramic, solid polymer or the like, which is substantially impermeable to fluids, is a high resistance material (i.e. an electrical insulator) and is substantially chemically inert to the electrolyte and decomposition products of the latter.
  • Membrane 36 in the form of a sheet with a substantially uniform thickness, for example, not more than approximately 5 mils, is selected from materials which exhibit selective permeability to the electro-active species which one desires to measure. For instance, where the species is gaseous oxygen, membrane 36 may be of a polymer such as polyethylene, polyvinyl chloride, rubber, or other known substances which provide a solid barrier selectively pervious to the gas.
  • Barrier materials are known which are selectively permeable to other electro-active species.
  • Appropriate means are provided for sealing the membrane across the opening to chamber 44, for instance, adhesives which are insoluble in the electrolyte and test fluid, an O-ring, or other known techniques or structures.
  • Anode 30 is formed as a substantially sheet-like element typically having a thickness of about 3 mils and being porous to both the electrolyte and electro-active species.
  • the anode is made of an electrically conductive material, preferably a noble metal such as platinum, gold or the like. To provide porosity, the anode may be provided as a mesh or screen as shown, as a spongy mass, or in other known configurations.
  • anode 30 is disposed within electrolyte 34 and is superposed adjacent membrane 36, i.e. arranged either in face-to-face contact with the latter, or, if the anode and membrane are in separated condition, then there is approximate parallelism of the adjacent surfaces of the anode and membrane with a stratum of electrolyte between them.
  • Cathode 32 in the form shown, is also a substantially sheet-like element which may be either porous or solid, preferably the latter, and its thickness is determined by cost and considerations of structural strength.
  • the cathode is also preferably made of a noble metal, for instance the same metal used as the anode.
  • Cathode 32 is also disposed within electrolyte 34 and is disposed in approximately parallel face-to-face relationship to the anode, but separated from the latter a short distance by appropriate nneans such as spacer 46.
  • spacer 46 is a substantially sheetlike porous element, such as a woven fabric.
  • the spacer is preferably formed of material which is electrically nonconductive, relatively chemically inert to the electrolyte and its decomposition products, and exhibits good dimensional stability with respect to variables such as temperature, pressure, solvents and the like, whereby the spacing between the anode and the cathode is maintained at a substantially constant value.
  • Typical materials from which such spacer may be made are nylon, polytetrafluorethylene, and the like.
  • the electrolyte is preferably an aqueous solution of a base, such as KOH, because in the operation of the device it is desired to avoid evolution of gaseous hydrogen at the anode.
  • the pH of the electrolyte should preferably be basic and generally not less than approximately pH 2 or 3.
  • the cathode and anode it is preferred to use materials which will respectively reduce oxygen and generate oxygen with maximum current efliciencies. Because of their low oxygen over-voltages and relative chemical inertness, the noble metals are thus preferred and both anode and cathode can be made of, for example, platinum.
  • FIG. 4 there is graphically shown the general current-voltage relationship in the present invention during operation.
  • the ordinate is shown as the current axis, the voltage axis being the abscissa. While the curve 48 is shown as being symmetrical about the origin, this is only for purposes of illustration and is not actually the case.
  • the oxygen at the cathode is electrically reduced. This produces a current I whose amplitude is a function of the concentration of gaseous oxygen present in the electrolyte.
  • the system consumes the species at one electrode and tends to generate a like quantity thereof at the other electrode, without changing the electrolyte pH.
  • the steady state equality between generation and consumption is, however, responsive to any change in concentration of the oxygen outside of the membrane. This is largely because of the geometry of the system wherein the generating electrode lies between the consuming electrode and membrane.
  • FIG. 3 there is shown graphically a concentration diagram taken across the electrode-membrane structure of the embodiment of FIG. 2.
  • the ordinate 52 represents the relative concentration of the particular electroactive species.
  • the absicca 54 represents distance from the cathode-electrolyte interface which is at the origin of the graph and hence, in a sense, the latter interface is line 52.
  • Lines 56 and 58 then represent the respective surfaces of the anode facing the cathode and the membrane; and line 60 is the outer surface of the membrane in contact with the test fluid.
  • line 58 can also be considered the anode-membrane interface.
  • distance between the various lines is representative of the thickness of the various elements but is not to be considered as necessarily showing the actual proper proportions.
  • the latter concentration is indicated by the horizontal portion of broken line 62 which extends from the test fluid into the membrane.
  • the concentration gradient represented by the remainder of broken line 62, extends from the anode-membrane interface to the cathode-electrolyte interface. The slope and position of line 62 will not change during steady state operation because of the equilibria established as heretofore described which results in no net transfer of oxygen across the membrane.
  • the response time is considerably reduced inasmuch as diffusion time through the membrane in enhanced.
  • the steady state current is approximately where K is a constant depending, inter alia, on the diffusion coeflicients, C is the concentration of the species in the test fluid and H and L are respectively the anode (generating here) thickness and inter-electrode spacing.
  • the spacing between the cathode and anode affects the sensitivity and response time, hence should be as small as possible without creating a dead short circuit. Typically, a spacing of l to 10 mils has proved quite satisfactory. Similarly, the spacing between the anode and membrane, if any, will also affect the response time and can be minimized without concern for short circuits.
  • the device shown in FIG. 5 also includes, in a configuration similar to FIG. 2, enclosure means 42 having a hollow 44 therein open to the outside of the enclosure means, the opening being sealed by membrane 36.
  • a generating electrode, such as anode 30, is disposed inside hollow 44 against the membrane.
  • a consuming electrode, such as cathode 32 is also disposed within hollow 44 and separated, as by separator 46, from the anode 36.
  • Appropriately fluid-sealed electrically conductive leads 46 and 47 are respectively attached to cathode 32 and anode 30 to provide electrical connection to the electrodes from the exterior of the enclosure means.
  • An electrolytic medium such as a fluid electrolyte 34, substantially occupies the remaining space within hollow 44.
  • a third or reference electrode 66 to which another electrically conductive lead 68 is attached to provide an electrical connection between electrode 66 and the exterior of the enclosure means.
  • electrode 66 is preferably an Ag-AgO electrode.
  • FIG. 6 there will be seen an electronic circuit for use with the embodiment of FIG. 5 to determine the current flow between anode and cathode as well as to provide high stability to the operation of the system.
  • the circuit of FIG. 6 comprises means for electrically connecting the circuit to electrodes of FIG. 5, and such means may comprise leads 68, 46 and 47 respectively adapted to be connected to reference electrode 66, cathode 32 and anode 30.
  • Lead 68 is also connected to lead 46 through a series resistor 70 and an electrical power source, such as battery 72, the latter being poled so that lead 46 is negative.
  • a point intermediate resistor 70 and the reference electrode is connected, as by lead 74, to the input of D.C.
  • a measuring instrument such as ammeter 78 is located preferably in the circuit between the amplifier and anode.
  • the amplifier and positive side of the battery should be appropriately grounded in order to avoid transient from extraneous phenomena.
  • amplifier 76 is a D.C. inverting amplifier which preferably exhibits high gain (in the order of thousands) and is also preferably stabilized as by internal negative feedback, chopper-stabilization or the like, all as well known in the art.
  • the reference electrode is positive with respect to cathode 32, but negative with respect to anode 30.
  • the gain of amplifier 76 is sufficiently high, the coupling of its output through anode 30 to reference electrode 66 constitutes a negative feedback loop which will tend to create a virtual ground at the input of the amplifier.
  • the potential of the reference electrode is therefore fixed at the virtual ground, and the potential between cathode 32 and the reference electrode is consequently maintained at a very stable level at which only oxgen will be reduced at the cathode.
  • a hollow container was formed of polymethylmethacrylate.
  • a cathode formed of 1 mil platinum metal foil of approximately 0.3 square centimeter per surface.
  • a platinum metal anode formed of 80 mesh gauze, 3 mil diameter wire, and having a mean thickness of 5 mils, was placed in the container and spaced from the cathode with a nylon fabric spacer having a thickness of approximately 5 mils.
  • an Ag-AgO reference electrode in the form of a very short piece of No. 16 gauge Wire.
  • the remainder of the container was filled with a 1M KOH aqueous solution, and the opening into the container was capped with a polytetrafluoroethylene membrane having a thickness of 0.5 mil.
  • the cathode potential was set at 0.7 volt with respect to the Ag-AgO electrode, and the device was operated at a temperature of 20 C.
  • the device was first operated with pure helium disposed against the surface of the membrane opposite the surface contacting the electrolyte, and a steady state current of 4.3 microamperes was obtained. Subsequently the outer surface of the membrane of the device was exposed to a number of various oxygen-containing fluids in samples of 0.2 cc. each, with the following results:
  • the electrolyte is aqueous KCl and the cathode is Ag-AgCl (thereby ensuring that no oxygen generation would occur within the apparatus)
  • the concentration of oxygen in a sample of similar size will be reduced approximately 70%.
  • the present invention when operated for the same period of time there was no detectable change in oxygen concentration in the test sample.
  • the electrolyte may be a molten salt
  • the enclosure means a membrane selected accordingly to have appropriate temperature resistant characteristics.
  • the anode and cathode of the present invention have been shown as substantially flat plates, of course other configurations which preserve the relative positioning of the electrodes and membrane may also be used.
  • the device may be constructed with the anode and cathode as concentric cylinders, the membrane lying along a portion of the exterior cylindrical surface of the anode.
  • the generating electrode is an anode and the consuming electrode is a cathode.
  • the generating electrode will be a negative electrode placed adjacent the membrane and the consuming electrode will be an anode or positive electrode.
  • An electrode assembly for measuring the concentration of a specific electro-chemically active species in a fluid comprising in combination:
  • barrier means for separating said electrolyte from said fluid, and being selectively permeable to said species, and in contact with said medium;
  • an electrical power source connected for biasing said first electrode means at a potential at which said species in said electrolyte will be consumed at said first electrode means; second electrode means of a material electrochemically inert to both said electrolyte and said species, said second electrode means being in contact with said medium and connected to said power source for completing a circuit in which a current from said source can flow through both said electrode means at a level which is a function of such consumption;
  • said electrolyte being one from which substantially only said species is electrolytically generable at said second electrode means at said current level, said second electrode means being biased by said power source at a potential at which said species is generable from said medium;
  • said second electrode means being so positioned with respect to said first electrode means and said barrier means that said species as generated at said second electrode means is available for consumption at said first electrode means in quantity dependent upon a tendency of said species to establish an equilibrium condition across said barrier means between concentration of said species respectively in said electrolyte and in said fluid.
  • An assembly as defined in claim 1 including means for measuring said current.
  • An assembly as defined in claim 1 including container means enclosing said electrolyte and said electrode means, said container means having said barrier means as a wall portion thereof.
  • barrier means comprises a membrane having opposite surfaces, one of which is in contact with said electrolyte and the other of which is adapted to contact said fluid.
  • An electrode assembly for measuring the concentration of a specific electrochemically reducible gas in a fluid comprising, in combination:
  • barrier means for separating said fluid and said medium, said barrier means being selectively permeable to said gas, and in contact with said medium;
  • an electrical power source connected to said cathode for establishing a cathodic potential at said first electrode, said cathode being adapted for reducing said gas in said medium at said cathodic potential, said source providing an electrical current flow at said cathode at a level which is a function of such reduction;
  • said medium being a medium from which only said gas is electrolytically generable at said anode at said current level, said anode being adapted for generating said gas from said medium at said current level and connected to said power source so as to complete a circuit between said anode and cathode and bias said anode at an anodic potential at which said gas can be generated from said medium;
  • said anode and cathode being positioned in spaced relation to one another and to said barrier means, and said potentials being established at magnitudes, such that said current flow tends to substantially steady state condition responsively to a tendency for an equilibrium condition to become established across said barrier means between the partial .pressures of said gas in said medium and said fluid.
  • An assembly as defined in claim 5 including means for maintaining the magnitude of said cathodic potential at said cathode at a substantially constant value.
  • said electrolytic medium comprises a first material from which said gas can be generated at said anode at said current level and anodic potential, and a second material which provides ionic charge transport;
  • An electrode assembly for measuring the concentration of a specific electrochemically active gas in a fluid according to the level of electrical current flowing at a polarographic cathode responsively to the availability at said cathode of said gas; said assembly comprising in combination;
  • barrier means for separating said fluid from said rifedium and being selectively permeable to said gas and in contact with said medium;
  • said polarographic cathode being of a material electrochemically inert to both said medium and said gas
  • an anode in contact with said medium and being of a material electrochemically inert to both said medium and gas, said anode being positioned wholly between said surface of said polarographic cathode and said barrier means and capable of generating said gas from said medium with a current efliciency substantially the same as the current efiiciency of consumption of said gas at said polarographic cathode, so that said gas as generated at said anode is available for consumption at said cathode in quantity dependent upon a tendency of said gas to establish across said barrier means an equilibrium condition between concentrations of said gas respectively in said medium and said fluid.
  • An assembly as defined in claim 8 including means for impressing on said polarographic electrode, a first potential above the polarization potential for said gas,
  • An electrode assembly for measuring the concentration of a specific electrochemically active gas in a fluid according to the level of electrical current flowing at a polarographic cathode responsively to the availability at said cathode of said gas; said assembly comprising in combination:
  • barrier means for separating said fluid from said medium and being selectively permeable to said gas and in contact with said medium;
  • said polarographic cathode being of a material electrochemically inert to both said medium and said gas, and having a surface in contact with said medium for electrolytically consuming said gas;
  • an anode in contact with said medium and being of a material electrochemically inert to both said medium and gas, said anode being positioned wholly between said surface of said polarographic cathode and said barrier means, for electrolytically generating said gas; a third electrode in contact with said medium; means for impressing (1) at said polarographic cathode a first potential which is above the polarization potential for said gas, (2) at said anode, a second A potential which is above the decomposition potential for said medium and (3) at said third electrode, a third potential between said first and second potentials, said first potential being fixed with respect to said third potential, said first and second potentials providing a current flow at said anode when said gas is present at said cathode, which current flow is equal and opposite to the current flow at said cathode, so that said gas as generated at said anode is available for consumption at said cathode in quantity dependent upon a tendency of said gas to establish an equilibrium condition, across said barrier means, between concentrations of said gas respectively in said
  • said means ,for impressing said potentials comprises an electrical power source connected through a series resistance between said polarographic and third electrodes, and a DC. amplifier means having the potential drop across said resistance as the input signal thereto, the output of said amplifier being connected to said second electrode so as to tend to maintain said potential drop at a minimum,
  • An electrode assembly for measuring the concentration of gaseous oxygen in a fluid comprising in combination:
  • barrier means selectively per- :meable to oxygen and impermeable to said fluid
  • a second electrode for electrolytically generating oxygen, and formed of an electrically conductive material substantially electrochemically inert to said medium and to oxygen, said second electrode being positioned between said first electrode and said' barrier means;
  • an electrolytic medium disposed within said space in contact with said electrodes and said barrier means, said electrolytic medium comprising a material from which said oxygen can be generated at said second electrode by passage of an electrical current therethrough;
  • An electrode assembly for measuring the concentration of an electrochemically reducible gas comprising, in combination:
  • a hollow container of electrically insulating material having an opening therein, a membrane sealing said opening and being selectively permeable to said gas and impermeable to liquids, a cathode of electrochemically inert metal disposed within said hollow of said container for electrolytically reducing said gas, a porous anode of electrochemically inert metal disposed in said hollow between said cathode and said membrane adjacent the latter for electrolytically gen erating said gas;
  • An electrode assembly as defined in claim 16 including means for impressing at said cathode, a potential above the polarization potential for said gas and means for impressing at said anode a potential above the potential necessary to produce said gas from said medium.
  • Method of measuring the concentration of an electrochemically active gas in a fluid comprising the steps of:
  • barrier means selectively permeable to said gas, and impermeable to both said medium and fluid; impressing a first potential on a first electrochemically inert metal electrode immersed in said medium and a second potential on a second electrochemically inert metal electrode immersed in said medium so as to cause a flow of current at said electrodes;
  • Method of measuring the concentration of gaseous oxygen in a fluid comprising the steps of:

Description

July 12, 1966 J. w. R055. JR 3,260,656
METHOD AND APPARATUS FOR ELECTROLYTIGALLY DETERMINING A SPECIES IN A FLUID Fzled Sept. 27, 1962 2 Sheets-Sheet 1 LOCAL DEPLETION TEST MEMBRANE LAYER FLUID F G (PRIOR ART) F IG. 2
GEN. ELECTRO- ELEC MEM- TEST LYTE TRODE BRANE FLUID z 56 ss 9 I- E -62 62 z w 0 g 60 U INVENTOR 52 JAMES w R088, JR.
DISTANCE BY F G 3 Rmfimub ATTORNEYS July 12, 1966 J. w. R055. JR 3,260,656
METHOD AND APPARATUS FOR ELECTROLYTIGALLY DETERMINING A SPECIES IN A FLUID Filed Sept. 27, 1962 2 Sheets-Sheet 2 INVENTOR Rm & SW
ATTORNEYS JAMES W ROSS, JR.
United States Patent C) York Filed Sept. 27, 1962, Ser. No. 226,533 19 Claims. (Cl. 204-1) Newton, Mass, assignor to (Iorning N.Y., a corporation of New This invention relates to electrochemical apparatus and more particularly to improved devices for electrically measuring the concentration of electrochemically active materials in fluids.
The term fluids as used herein is intended to include gases, liquids, vapors and mixtures thereof. Heretofore, in the determination of the concentration in fluids of an electrochemically active species (i.e. a substance such as an ion which is capable of being either reduced oroxidized at an electrode), electrochemical devices have been used in which an electrical characteristic of the species is measured and correlated with the concentration. Polarographic devices, for example, usually measure a characteristic potential at which such a species is reduced, and a diflusion current proportional to the concentration. An improvement on the basic polarographic apparatus is the well-known Clark apparatus as disclosed in US. Patent No. 2,913,386 issued November 17, 1959. The latter employs a dual electrode structure immersed in an electrolyte and encased at least in part in a membrane which is permeable to a predetermined species, for instance, gaseous oxygen. Typically, when used for oxygen analysis, the cathode is formed of platinum and is located closely adjacent the membrane; the anode is formed of silversilver chloride; and the electrolyte is an aqueous alkali halide solution. In operation of such a device, oxygen in a test fluid outside of the membrane permeates the latter and is presumably reduced at the cathode to water in accordance with the overall equation 2H++1/2O2+2 H20 It will be apparent that the Clark device is intended to completely reduce the oxygen permeating the membrane. The current (2e) necessary to effect this reduction is a measure then of the oxygen concentration in the test fluid. In determining oxygen concentration this device typically employs the Ag-AgCl anode with a KCl electrolytic solution. Hence, the anode reaction is Ag+Cl- AgCl+e As the electrode operates, H+ is consumed at the cathode, changing the pI-I of the electrolyte in time. For prolonged operation, a buflFer is therefore required.
While devices of this type have proved satisfactory for many purposes, certain problems arise in some applications. For instance, referring to FIG. 1, there is shown graphically a concentration diagram for such devices. In this diagram, the ordinate 20 is the scale from zero of the relative concentration of oxygen, and the abscissa represents distance from the cathode-membrane interface toward a test fluid. The position of the cathode-membrane interface (neglecting any small displacement between the two) is at line 20. Line 22., parallel to the ordinate, then represents the membrane-test fluid interface. The distance between lines 20 and 22 is representative of the membrane thickness. Now it may be assumed that the concentration of oxygen in the test fluid adjacent the outer face of the membrane is constant, as shown by the horizontal portion of broken line 24, and that the consumption of oxygen at the cathode is complete so that the concentration of oxygen at the cathode-membrane interface is substantially zero. Under such circumstances,
the concentration gradient, represented by the remainder of broken line 24, across the membrane is approximately linear and its slope is an inverse function of the membrane thickness.
However, during actual operation of the device, as oxygen is consumed at the cathode, there is a continual flow of the gas from the test fluid through the membrane to replenish the oxygen supply being consumed or reduced. If the oxygen in the test fluid adjacent the outer surface of the membrane is not continually replenished so as to be maintained at a constant level, the concentration gradient will then extend out into the test fluid, and its slope will become non-linear and reduced as shown at broken line 26 in FIG. 1, due to the local depletion of oxygen in a layer shown between lines 22 and 28. With continued operation of the device and no replenishment of oxygen, the local depletion layer will continue to expand further out into the test fluid, distorting the concentration gradient more and more. The distortion of concentration gradient reduces the measurement sensitivity and changes the mass flow rate of oxygen through the membrane to the cathode, making measurement uncertain and even spurious over a period of time. In order to avoid such occurrence, it is customary to provide means for breaking up any depletion layer, as for instance by stirring.
Further, if the fluid under measurement is a minute sample to which access is restricted, as in biological cells for example, depletion will continue until all of the oxygen is consumed. Because access to the fluid is restricted by the cell walls which act as barriers, the consumed oxygen cannot readily be renewed; the measurements in a short time become inconclusive. Additionally, even assuming that local depletion layers on the outer membrane surface can be avoided, in order to maintain the gas concentration at the cathode substantially at zero with reasonable current consumption the input flow rate of the oxygen must be controlled. This is usually done by providing a relatively thick membrane which, however, acts to slow the response time of the device to changes in oxygen concentration in the test fluid.
Accordingly, the present invention contemplates the provision of improvements in electrochemical analytic devices by virtue of which the sensitivity and response time are enhanced, and which improvements minimize material changes in the concentration of the species in the fluid under measurement during the measurement time. A principal object of the present invention is therefore to prove an improved electrochemical analytical device.
Further objects of the present invention are to provide an electrochemical device including enclosure means (for an electrolytic medium, at least a portion of the enclosure means being formed of barrier means selectively permeable to a predetermined spaced relation to one another within the enclosure means, means *for impressing -a predetermined potential difterence across the electrode, the electrolytic medium being one from which the elect-ro-active species can be liberated by passage of electrical current between said electrodes, the electrolytic medium bridging the electrodes and being in contact with the barrier means; to provide such a device in which one electrode is adapted to consume said species and the other electrode is adapted to generate said species; to provide such a device in which the cathode is adapted for reduction of said species and the anode is adapted to generate said species; to provide such a device in which the cathode is adapted for reduction of said species and the anode is adapted to generate said species in dependence upon said reduction, said anode being adjacent the barrier means and between the latter and the cathode; to provide such a device in which the anodic current flow is maintained at the same absolute value as the cathodic current flow; and to provide such a device in which the cathodic current is dependent upon the equilibrium between the species generated at the appropriate electrode and the concentration of the species which is outside of the enclosure means and free to permeate the barrier means.
Other objects are to provide such a device including a reference electrode which is in contact with the electrolytic medium and provides a high stability to the potential at the consuming electrode; to provide such a device which does not substantially aifect or deplete the concentration of the electro-active species outside of the enclosure means except (briefly, at all, during transient changes in said concentration) for appreciable time periods and in restricted samples of fluid; and to provide such a device in which the sensitivity and response time to changes in the concentration of electro-active species in the test fluid are markedly improved. Yet other objects of the present invention are to provide an electrical circuit for use with an electrochemical analytic device of the type described; and to provide such an electrical circuit which includes a negative feedback loop for stabilizing the potential between a reference electrode and a consuming electrode.
Other objects of the invention will in part be obvious and will .in part appear hereinafter. The invention accordingly comprises the apparatus possessing the construction, combination of elements and arrangement of parts which are exemplified in the following detailed disclosure, and the scope of the application of which will be indicated in the claims. [For a fuller understanding of the nature and objects of the present invention, reference should be had to the following detailed description taken in connection with the accompanying drawings wherein:
FIG. -1 is a graphical representation of the concentration gradient across the selectively permeable membrane in prior art devices as hereinbef-ore described;
FIG. 2 is a diagrammatic cross-sectional view of one embodiment of the present invention;
FIG. 3 is a graphical representation of a concentration gradient across a portion of the electrode-membrane structure of the embodiment shown in FIG. 2;.
FIG. 4 is a graphical representation of the current-voltage relationship at the electrodes in the structure of FIG. 2;
FIG. 5 is a diagrammatic cross-sectional representation of another embodiment of the present invention; and
FIG. '6 is a diagram of an electrical measuring circuit particularly adapted for use with the electrode structure of FIG. 5.
To effect the objects heretofore set forth the present invention generally comprises a pair of electrodes electrically coupled through an electrolytic medium of predetermined fixed characteristics. The medium is isolate-d from the test fluid under measurement by barrier means selectively permeable to the electro-active species which is to be detected and measured in the test fluid. A first electrode is adapted to consume the desired electro-active species, while the other electrode is adapted to produce or generate said species in dependence on the consumption activity of the first electrode. Thus, in operation, there is a steady state equality established between consumption and generation within the electrolyte. The electrode-membrane structure is such that this steady state equality is in turn responsive to an equilibrium between relative concentrations of the species on both sides of the barrier means. It will be seen, therefore, that in the present invention, during steady state conditions, there is no net transfer of species through the barrier means; only during transient changes in the concentration of the species in the test fluid will there be a small net transfer which rapidly decays as an internal steady state is reestablished. Consequently, the consumption of the electro-active species is minimized and changes in the concentration of the species in the fluid under measurement which may be ascribed to the analytical activity of the apparatus, are minute and quickly and automatically compensated.
The term electro-active species as used herein is intended to mean any group of identical chemical entities such as ions, molecules, atoms, etc., which are capable of being electrically oxidized or reduced. Where the species is a gas e.g. oxygen, chlorine or the like, which is dissolved in or mixed with another fluid, rather than referring to concentration, it is perhaps more accurate to refer to the equilibrium partial pressure. This is so because a gas may exhibit different solubilities with respect to difrferent fluids. Hence, although the equilibrium partial pressure (hereinafter referred to as the tension) of the gas in one fluid may be precisely equal to the tension of the same gas in another fluid, the concentrations of gas with respect to each of the fluids are not necessarily the same. However, where the gas tensions on opposite sides of a gas-permeable membrane are in equilibrium, the tension on one side is proportional to the concentration on the other side.
Referring now to FIG. 2, there will be seen one embodiment of the present invention in which there is shown a structure comprising a first electrode or anode 30, a second electrode or cathode 32, an electrolytic medium 34 which electrolytically coupled the anode and cathode, and selectively permeable barrier means, such as membrane 36. Means, such as battery 38, are provided for applying an appropriate potential across the cathode and anode through respective leads 46 and 47. The invention also may include means shown schematically as meter 40, for measuring current flow in the cathode anode circuit. In order to encase the electrodes and the electrolytic medium there is provided enclosure means 42 which preferably incorporates membrane 36 as a Wall portion thereof.
Enclosure means 42 is preferably formed with a substantially hollow chamber 44 interiorly thereof, the chamber having at least one opening to the outside of the enclosure means. Membrane 36 is so disposed as to completely cover the opening in chamber 44. The electrolytic medium (i.e. a medium capable of providing both positive and negative ionic charge transport as by ions provided from a disassociatable compound in a polar solvent, or by ions provided by a molten salt or the like), for example an aqueous electrolyte, is disposed within the chamber in suflicient quantity to maintain a continuous electrical contract between electrodes. The enclosure means preferably then is formed as a liquid-tight container so that the electrolyte cannot leak out. The electrolyte is preferably selected to be one whose ions require a more negative potential for reduction than does hydrogen and require a more positive potential for oxidation than does water or hydroxyl ion. The dilference between these more negative and positive potentials is generally termed the decomposition voltage of the electrolyte.
The walls of chamber 44, other than membrane 36, are preferably made of a material, such as glass, ceramic, solid polymer or the like, which is substantially impermeable to fluids, is a high resistance material (i.e. an electrical insulator) and is substantially chemically inert to the electrolyte and decomposition products of the latter. Membrane 36, in the form of a sheet with a substantially uniform thickness, for example, not more than approximately 5 mils, is selected from materials which exhibit selective permeability to the electro-active species which one desires to measure. For instance, where the species is gaseous oxygen, membrane 36 may be of a polymer such as polyethylene, polyvinyl chloride, rubber, or other known substances which provide a solid barrier selectively pervious to the gas. Barrier materials are known which are selectively permeable to other electro-active species. Appropriate means (not shown) are provided for sealing the membrane across the opening to chamber 44, for instance, adhesives which are insoluble in the electrolyte and test fluid, an O-ring, or other known techniques or structures.
Anode 30 is formed as a substantially sheet-like element typically having a thickness of about 3 mils and being porous to both the electrolyte and electro-active species. The anode is made of an electrically conductive material, preferably a noble metal such as platinum, gold or the like. To provide porosity, the anode may be provided as a mesh or screen as shown, as a spongy mass, or in other known configurations. In the form shown, anode 30 is disposed within electrolyte 34 and is superposed adjacent membrane 36, i.e. arranged either in face-to-face contact with the latter, or, if the anode and membrane are in separated condition, then there is approximate parallelism of the adjacent surfaces of the anode and membrane with a stratum of electrolyte between them.
Cathode 32, in the form shown, is also a substantially sheet-like element which may be either porous or solid, preferably the latter, and its thickness is determined by cost and considerations of structural strength. The cathode is also preferably made of a noble metal, for instance the same metal used as the anode. Cathode 32 is also disposed within electrolyte 34 and is disposed in approximately parallel face-to-face relationship to the anode, but separated from the latter a short distance by appropriate nneans such as spacer 46.
In the preferred form, spacer 46 is a substantially sheetlike porous element, such as a woven fabric. The spacer is preferably formed of material which is electrically nonconductive, relatively chemically inert to the electrolyte and its decomposition products, and exhibits good dimensional stability with respect to variables such as temperature, pressure, solvents and the like, whereby the spacing between the anode and the cathode is maintained at a substantially constant value. Typical materials from which such spacer may be made are nylon, polytetrafluorethylene, and the like. It will be seen then that the electrode structure of FIG. 2 is that of a sandwich in which the anode is spaced from the cathode and retained in between the latter and the membrane, other portions of the volume between the membrane and cathode being substantially filled with electrolyte.
In describing the operation of the embodiment of FIG. 2, it will be exemplary to consider oxygen as the electroactive species. In such case, the electrolyte is preferably an aqueous solution of a base, such as KOH, because in the operation of the device it is desired to avoid evolution of gaseous hydrogen at the anode. Hence, the pH of the electrolyte should preferably be basic and generally not less than approximately pH 2 or 3. In selecting the cathode and anode in this instance, it is preferred to use materials which will respectively reduce oxygen and generate oxygen with maximum current efliciencies. Because of their low oxygen over-voltages and relative chemical inertness, the noble metals are thus preferred and both anode and cathode can be made of, for example, platinum. If the potential applied across the anode and cathode is established well below the decomposition voltage of the electrolyte, and there is no oxygen available in the electrolyte (as from diffusion into the electrolyte through the membrane, or from being dissolved in the latter), only a virtually constant, minute, residual current will flow in the cathode-anode circuit. If, however, a supply of oxygen is presented to the outer surface of membrane 36, as for instance, by contacting the latter with a liquid having a dissolved oxygen content or by contacting the latter with a gas which comprises oxygen, because of the selective permeability of the membrane some oxygen will diffuse through the latter to its inner face and thence into the electrolyte to the cathode. If the potential across the electrodes is above the reduction potential of oxygen, although below the decomposition potential of the electrolyte, oxygen present at the cathode will be reduced. The reduction process is believed to be according to the same equation heretofore used in describing the cathodic reduction in the Clark apparatus.
Referring now to FIG. 4 there is graphically shown the general current-voltage relationship in the present invention during operation. The ordinate is shown as the current axis, the voltage axis being the abscissa. While the curve 48 is shown as being symmetrical about the origin, this is only for purposes of illustration and is not actually the case. At a point where there is a predetermined negative voltage -E, the oxygen at the cathode is electrically reduced. This produces a current I whose amplitude is a function of the concentration of gaseous oxygen present in the electrolyte. With a negative current -I, equal in magnitude to I, now flowing at the anode, the latter is at a positive voltage +E, shown at point 51, predetermined by the nature of the anode material and electrolyte. With proper choice of parameters in the example described above, at the anode the current oxidizes the water in the electrolyte, generating oxygen according to the following:
Hence the system consumes the species at one electrode and tends to generate a like quantity thereof at the other electrode, without changing the electrolyte pH. This leads rapidly to an internal or interelectrode steady state condition between the consumption and generation of the species, and the current flow is therefore a measure of the 0 present in the system. The steady state equality between generation and consumption is, however, responsive to any change in concentration of the oxygen outside of the membrane. This is largely because of the geometry of the system wherein the generating electrode lies between the consuming electrode and membrane. The gas tensions on both sides of the membrane will tend to reach an equilibrium with one another inasmuch as a high tension outside the membrane will result in net diffusion of the gas throughout the latter toward the anode, and conversely a higher tension inside the membrane would result in net gaseous diffusion through the membrane from the anode to the test fluid. Thus, any change in gas tension outside the membrane will upset the internal steady state of the system, forcing it to a new steady state by either increase or decreased consumption of gas and a corresponding increase or decrease in gas generation. Each change in gas generation is thus in a direction tending to establish equilibrium between the gas tensions on opposite sides of and across the membrane. Every change in the internal steady state is, of course, accompanied by a chance in the current flowing between the electrodes. It will thus be seen that in the equilibrium condition of gas tension across the membrane, the current flow is constant and there is no net transfer of gas through the membrane. On the other hand, if the gas tension in the test fluid should change, a transient condition will exist until a new steady state is established internally which again provides a gas tension equivalency on both faces of the membrane. Hence, depletion of oxygen is minimized at points adjacent the outside surface of the membrane i.e. the surface contacting the test fluid.
Referring now to FIG. 3, there is shown graphically a concentration diagram taken across the electrode-membrane structure of the embodiment of FIG. 2. As in FIG. 1, the ordinate 52 represents the relative concentration of the particular electroactive species. The absicca 54 represents distance from the cathode-electrolyte interface which is at the origin of the graph and hence, in a sense, the latter interface is line 52. Lines 56 and 58 then represent the respective surfaces of the anode facing the cathode and the membrane; and line 60 is the outer surface of the membrane in contact with the test fluid. For the sake of clarity, no displacement between anode and membrane is shown, hence line 58 can also be considered the anode-membrane interface. The
distance between the various lines is representative of the thickness of the various elements but is not to be considered as necessarily showing the actual proper proportions. Using again the example of oxygen and assuming for simplicity, that the oxygen exhibits the same tension in both electrolyte and test fluid and the concentration of oxygen in the test fluid is constant, the latter concentration is indicated by the horizontal portion of broken line 62 which extends from the test fluid into the membrane. The concentration gradient, represented by the remainder of broken line 62, extends from the anode-membrane interface to the cathode-electrolyte interface. The slope and position of line 62 will not change during steady state operation because of the equilibria established as heretofore described which results in no net transfer of oxygen across the membrane. However, during a transient change in oxygen concentration in the test fluid, although the horizontal portion of line 62 extending into the test fluid from membrane surface 60 will shift its level, this only results in a temporaray departure from a zero slope of the concentration level across the membrane. This zero slope is quickly re-established by the corresponding change in generation of oxygen at the anode. Hence, substantially no depletion layer will be created in the test fluid.
If the membrane is made very thin, for example, in the nature of 0.5 mils, the response time is considerably reduced inasmuch as diffusion time through the membrane in enhanced. Presupposing constant diffusion coefficients for the membrane, electrolyte and anode, the steady state current is approximately where K is a constant depending, inter alia, on the diffusion coeflicients, C is the concentration of the species in the test fluid and H and L are respectively the anode (generating here) thickness and inter-electrode spacing.
It is apparent that the spacing between the cathode and anode affects the sensitivity and response time, hence should be as small as possible without creating a dead short circuit. Typically, a spacing of l to 10 mils has proved quite satisfactory. Similarly, the spacing between the anode and membrane, if any, will also affect the response time and can be minimized without concern for short circuits.
Referring now to FIG. there will be seen another embodiment of the present invention similar in many respects to the embodiment of FIG. 2, and wherein like numerals denote like parts. The device shown in FIG. 5 also includes, in a configuration similar to FIG. 2, enclosure means 42 having a hollow 44 therein open to the outside of the enclosure means, the opening being sealed by membrane 36. A generating electrode, such as anode 30, is disposed inside hollow 44 against the membrane. A consuming electrode, such as cathode 32, is also disposed within hollow 44 and separated, as by separator 46, from the anode 36. Appropriately fluid-sealed electrically conductive leads 46 and 47 are respectively attached to cathode 32 and anode 30 to provide electrical connection to the electrodes from the exterior of the enclosure means. An electrolytic medium, such as a fluid electrolyte 34, substantially occupies the remaining space within hollow 44. Contacting the electrolyte and spaced from the other electrodes and membrane is a third or reference electrode 66 to which another electrically conductive lead 68 is attached to provide an electrical connection between electrode 66 and the exterior of the enclosure means.
Where this latter embodiment is intended to measure concentration of, for example, oxygen, the elements thereof can be selected and formed in the manner and of the materials heretofore described in connection with the embodiment of FIG. 2, except that electrode 66 is preferably an Ag-AgO electrode.
.Referring now to FIG. 6 there will be seen an electronic circuit for use with the embodiment of FIG. 5 to determine the current flow between anode and cathode as well as to provide high stability to the operation of the system. The circuit of FIG. 6 comprises means for electrically connecting the circuit to electrodes of FIG. 5, and such means may comprise leads 68, 46 and 47 respectively adapted to be connected to reference electrode 66, cathode 32 and anode 30. Lead 68 is also connected to lead 46 through a series resistor 70 and an electrical power source, such as battery 72, the latter being poled so that lead 46 is negative. A point intermediate resistor 70 and the reference electrode is connected, as by lead 74, to the input of D.C. voltage amplifying device or amplifier 76, the output of the latter being coupled to the anode through lead 47. A measuring instrument such as ammeter 78 is located preferably in the circuit between the amplifier and anode. The amplifier and positive side of the battery should be appropriately grounded in order to avoid transient from extraneous phenomena.
In operation of the device shown in connection with FIGS. 5 and 6, the presence of a species in the electrolyte permits current flow between the cathode and reference electrode, creating a potential across resistor 70 due to the IR drop therein. The voltage across resistor 70 is amplified by the gain of amplifier 76 and applied to anode 30. It will thus be apparent that amplifier 76 is a D.C. inverting amplifier which preferably exhibits high gain (in the order of thousands) and is also preferably stabilized as by internal negative feedback, chopper-stabilization or the like, all as well known in the art. Thus the reference electrode is positive with respect to cathode 32, but negative with respect to anode 30. If the gain of amplifier 76 is sufficiently high, the coupling of its output through anode 30 to reference electrode 66 constitutes a negative feedback loop which will tend to create a virtual ground at the input of the amplifier. The potential of the reference electrode is therefore fixed at the virtual ground, and the potential between cathode 32 and the reference electrode is consequently maintained at a very stable level at which only oxgen will be reduced at the cathode.
The following example is illustrative of the construction and operation of a device of the type shown in connection with FIGS. 5 and 6. A hollow container was formed of polymethylmethacrylate. In the container was placed a cathode formed of 1 mil platinum metal foil of approximately 0.3 square centimeter per surface. a platinum metal anode formed of 80 mesh gauze, 3 mil diameter wire, and having a mean thickness of 5 mils, was placed in the container and spaced from the cathode with a nylon fabric spacer having a thickness of approximately 5 mils. In contact with the electrolyte there was also installed an Ag-AgO reference electrode in the form of a very short piece of No. 16 gauge Wire. The remainder of the container was filled with a 1M KOH aqueous solution, and the opening into the container was capped with a polytetrafluoroethylene membrane having a thickness of 0.5 mil. In operation, the cathode potential was set at 0.7 volt with respect to the Ag-AgO electrode, and the device was operated at a temperature of 20 C.
In order to establish the backgriund current, the device was first operated with pure helium disposed against the surface of the membrane opposite the surface contacting the electrolyte, and a steady state current of 4.3 microamperes was obtained. Subsequently the outer surface of the membrane of the device was exposed to a number of various oxygen-containing fluids in samples of 0.2 cc. each, with the following results:
Sample: Current in microamperes Air saturated water 17.3 Air 17.3 O 59.6
All readings reached a constant level within a maximum of one minute after exposure to the sample. Each reading stayed constant for more than 3 hours after the initial transient. Despite the dilferent mobilities of the oxygen in water and in air, the readings achieved with respect to air and air saturated water were nevertheless identical and remarkably stable, indicating that in fact there was no net oxygen dfilusion through the membrane during steady state operation.
If one uses a similarly constructed apparatus in which however the electrolyte is aqueous KCl and the cathode is Ag-AgCl (thereby ensuring that no oxygen generation would occur within the apparatus), after 40 minutes the concentration of oxygen in a sample of similar size will be reduced approximately 70%. On the other hand, in the present invention, when operated for the same period of time there was no detectable change in oxygen concentration in the test sample.
It will be apparent to those skilled in the art that many modifications of the invention as thus described can be made. For example, a large number of electrolytes may be used. Indeed, under some circumstances the electrolyte may be a molten salt, and the enclosure means a membrane selected accordingly to have appropriate temperature resistant characteristics. While the anode and cathode of the present invention have been shown as substantially flat plates, of course other configurations which preserve the relative positioning of the electrodes and membrane may also be used. For example, the device may be constructed with the anode and cathode as concentric cylinders, the membrane lying along a portion of the exterior cylindrical surface of the anode. It will also be apparent that where the species to be measured is reducible, the generating electrode is an anode and the consuming electrode is a cathode. However, if the species to be measured is oxidizable, the generating electrode will be a negative electrode placed adjacent the membrane and the consuming electrode will be an anode or positive electrode.
Since certain changes may be made in the above apparatus without departing from the scope of the invention herein involved it is intended that all matter contained in the above description or shown in the accompanying drawing shall be interpreted in an illustrative and not in a limiting sense.
What is claimed is:
1. An electrode assembly for measuring the concentration of a specific electro-chemically active species in a fluid, said assembly comprising in combination:
a liquid electrolyte;
first electrode means of a material electrochemically inert to both said electrolyte and said species and in contact with said medium;
barrier means for separating said electrolyte from said fluid, and being selectively permeable to said species, and in contact with said medium;
an electrical power source connected for biasing said first electrode means at a potential at which said species in said electrolyte will be consumed at said first electrode means; second electrode means of a material electrochemically inert to both said electrolyte and said species, said second electrode means being in contact with said medium and connected to said power source for completing a circuit in which a current from said source can flow through both said electrode means at a level which is a function of such consumption;
said electrolyte being one from which substantially only said species is electrolytically generable at said second electrode means at said current level, said second electrode means being biased by said power source at a potential at which said species is generable from said medium; and
said second electrode means being so positioned with respect to said first electrode means and said barrier means that said species as generated at said second electrode means is available for consumption at said first electrode means in quantity dependent upon a tendency of said species to establish an equilibrium condition across said barrier means between concentration of said species respectively in said electrolyte and in said fluid.
2. An assembly as defined in claim 1 including means for measuring said current.
3. An assembly as defined in claim 1 including container means enclosing said electrolyte and said electrode means, said container means having said barrier means as a wall portion thereof.
4. An assembly as defined in claim 1 wherein said barrier means comprises a membrane having opposite surfaces, one of which is in contact with said electrolyte and the other of which is adapted to contact said fluid.
5. An electrode assembly for measuring the concentration of a specific electrochemically reducible gas in a fluid, said assembly comprising, in combination:
a cathode of an electrochemically inert material;
an anode of an electrochemically inert material;
an electrolytic medium in contact with both said cathode and anode;
barrier means for separating said fluid and said medium, said barrier means being selectively permeable to said gas, and in contact with said medium;
an electrical power source connected to said cathode for establishing a cathodic potential at said first electrode, said cathode being adapted for reducing said gas in said medium at said cathodic potential, said source providing an electrical current flow at said cathode at a level which is a function of such reduction;
said medium being a medium from which only said gas is electrolytically generable at said anode at said current level, said anode being adapted for generating said gas from said medium at said current level and connected to said power source so as to complete a circuit between said anode and cathode and bias said anode at an anodic potential at which said gas can be generated from said medium;
said anode and cathode being positioned in spaced relation to one another and to said barrier means, and said potentials being established at magnitudes, such that said current flow tends to substantially steady state condition responsively to a tendency for an equilibrium condition to become established across said barrier means between the partial .pressures of said gas in said medium and said fluid.
6. An assembly as defined in claim 5 including means for maintaining the magnitude of said cathodic potential at said cathode at a substantially constant value.
7. An assembly as defined in claim 5 wherein said electrolytic medium comprises a first material from which said gas can be generated at said anode at said current level and anodic potential, and a second material which provides ionic charge transport;
said source being connected for maintaining the magnitude of said anodic potential below the decomposition potential of said second material and above the poten- {ial 1at which said gas can be generated at said current eve 8. An electrode assembly for measuring the concentration of a specific electrochemically active gas in a fluid according to the level of electrical current flowing at a polarographic cathode responsively to the availability at said cathode of said gas; said assembly comprising in combination;
a liquid medium electrolytically and anodically decomposable to generate only said gas;
barrier means for separating said fluid from said rifedium and being selectively permeable to said gas and in contact with said medium;
said polarographic cathode being of a material electrochemically inert to both said medium and said gas,
and having a surface in contact with said medium for electrolytically consuming said gas;
an anode in contact with said medium and being of a material electrochemically inert to both said medium and gas, said anode being positioned wholly between said surface of said polarographic cathode and said barrier means and capable of generating said gas from said medium with a current efliciency substantially the same as the current efiiciency of consumption of said gas at said polarographic cathode, so that said gas as generated at said anode is available for consumption at said cathode in quantity dependent upon a tendency of said gas to establish across said barrier means an equilibrium condition between concentrations of said gas respectively in said medium and said fluid.
9. An assembly as defined in claim 8 wherein said second electrode is positioned in contact with said barrier means, said second electrode being porous to both said electrolytic medium and said gas.
10. An assembly as defined in claim 9 wherein said second electrode is a mesh.
11. An assembly as defined in claim 8 including means for impressing on said polarographic electrode, a first potential above the polarization potential for said gas,
" and means for impressing on said second electrode a second potential which is above the potential required for generation of said gas from said medium by electrolytic decomposition.
12. As assembly as defined in claim 11 including a third electrode contacting said medium and spaced from said polarographic and second electrode, and means for maintaining said third electrode at a reference potential between said first and second potentials and fixed with respect to said first potential.
13. An electrode assembly for measuring the concentration of a specific electrochemically active gas in a fluid according to the level of electrical current flowing at a polarographic cathode responsively to the availability at said cathode of said gas; said assembly comprising in combination:
' a liquid medium electrolytically and anodically decomposable to generate only said gas;
barrier means for separating said fluid from said medium and being selectively permeable to said gas and in contact with said medium;
said polarographic cathode being of a material electrochemically inert to both said medium and said gas, and having a surface in contact with said medium for electrolytically consuming said gas;
an anode in contact with said medium and being of a material electrochemically inert to both said medium and gas, said anode being positioned wholly between said surface of said polarographic cathode and said barrier means, for electrolytically generating said gas; a third electrode in contact with said medium; means for impressing (1) at said polarographic cathode a first potential which is above the polarization potential for said gas, (2) at said anode, a second A potential which is above the decomposition potential for said medium and (3) at said third electrode, a third potential between said first and second potentials, said first potential being fixed with respect to said third potential, said first and second potentials providing a current flow at said anode when said gas is present at said cathode, which current flow is equal and opposite to the current flow at said cathode, so that said gas as generated at said anode is available for consumption at said cathode in quantity dependent upon a tendency of said gas to establish an equilibrium condition, across said barrier means, between concentrations of said gas respectively in said medium and said fluid.
14. An assembly as defined in claim 13 wherein said means ,for impressing said potentials comprises an electrical power source connected through a series resistance between said polarographic and third electrodes, and a DC. amplifier means having the potential drop across said resistance as the input signal thereto, the output of said amplifier being connected to said second electrode so as to tend to maintain said potential drop at a minimum,
15. An electrode assembly for measuring the concentration of gaseous oxygen in a fluid, said assembly comprising in combination:
means defining an electrolyte space and having as a wall portion thereof barrier means selectively per- :meable to oxygen and impermeable to said fluid;
a first electrode of an electrochemically inert material and adapted to polarographically reduce said oxygen and disposed within said space in contact with said medium;
a second electrode for electrolytically generating oxygen, and formed of an electrically conductive material substantially electrochemically inert to said medium and to oxygen, said second electrode being positioned between said first electrode and said' barrier means;
an electrolytic medium disposed within said space in contact with said electrodes and said barrier means, said electrolytic medium comprising a material from which said oxygen can be generated at said second electrode by passage of an electrical current therethrough; and
means for effecting a current between said electrodes through said medium for simultaneous and substantially equal consumption and generation of oxygen at the respective electrodes in dependence upon establishment of an equilibrium between the partial pressures of oxygen at each side of said barrier means when the side of said barrier means opposite said electrolytic medium is in contact with said fluid.
16. An electrode assembly for measuring the concentration of an electrochemically reducible gas, said assembly comprising, in combination:
a hollow container of electrically insulating material having an opening therein, a membrane sealing said opening and being selectively permeable to said gas and impermeable to liquids, a cathode of electrochemically inert metal disposed within said hollow of said container for electrolytically reducing said gas, a porous anode of electrochemically inert metal disposed in said hollow between said cathode and said membrane adjacent the latter for electrolytically gen erating said gas;
means spacing said cathode from said anode, an electrolytic medium so disposed within said hollow as to form an ionically conductive path between said cathode and anode while in contact with said membrane, said electrolytic medium being capable of being so oxidized by an electrical current at said anode as to produce only said gas which is therefore available for reduction at said cathode in quantity dependent upon a tendency of said gas to establish across said barrier means an equilibrium condition between concentrations of said gas respectively in said medium and said fluid.
17. An electrode assembly as defined in claim 16 including means for impressing at said cathode, a potential above the polarization potential for said gas and means for impressing at said anode a potential above the potential necessary to produce said gas from said medium.
18. Method of measuring the concentration of an electrochemically active gas in a fluid comprising the steps of:
providing a body of electrolytic medium from which 70 said gas can be electrolytically generated;
diffusing said gas between said fluid and said medium through barrier means selectively permeable to said gas, and impermeable to both said medium and fluid; impressing a first potential on a first electrochemically inert metal electrode immersed in said medium and a second potential on a second electrochemically inert metal electrode immersed in said medium so as to cause a flow of current at said electrodes;
positioning said electrodes in spaced relation to one another and to said barrier means, and maintaining said potentials at magnitude and values at which said current flow causes at said electrodes a redox reaction in said body so that there is electrolytic generation of said gas at one electrode tending to an equality with an electrolytic consumption of said gas at the other electrode according to a tendency of said gas to establish an equilibrium of the partial pressures of said gas on opposite sides of said barrier means and the net diffusion of said gas through said barrier means is minimized, and,
measuring the magnitude of said current flow.
19. Method of measuring the concentration of gaseous oxygen in a fluid, comprising the steps of:
providing a body of electrolytic medium from which oxygen can be electrolytically generated,
contacting opposite sides of a membrane, Which is selectively permeable to oxygen, respectively with said fluid and said medium so as to permit oxygen diifusion through said membrane;
impressing first and second potentials respectively on an anode and cathode, both of electrochemically inert metals, in contact with said body, said anode being positioned in spaced-apart relation to and between said cathode and said membrane;
maintaining said potentials at values at which current flows in said body between said anode and cathode to generate oxygen at said anode responsive to a simultaneous reduction of oxygen at said cathode, the rate of oxygen generation being responsive to a tendency of the partial pressures of oxygen in said fluid and medium to establish a substantially static equilibrium across said membrane; and measuring said current flow,
References Cited by the Examiner UNITED STATES PATENTS 2,370,871 3/1945 Marks 204-1 2,758,079 8/1956 Eckfeldt 204- 2,805,191 9/1957 Hersch 204-1 2,898,282 8/1959 Flock et a1 204-195 2,912,367 11/ 1959 Asendorf et al 204-1 3,000,805 9/1961 Carritt et al. 204-195 3,022,241 2/ 1962 Jessop 204-195 3,028,317 4/1962 Wilson et al. 204-1 3,038,848 6/1962 Brewer et al 204-195 3,070,539 12/1962 Arthur et al. 204-195 3,088,905 5/1963 Glover 204-195 3,098,813 7/1963 Beebe et a1 204-1 3,160,577 12/1964 Nolan 204-195 JOHN H. MACK, Primary Examiner.
MURRAY A. TILLMAN, WINSTON A. DOUGLAS,

Claims (1)

18. METHOD OF MEASURING THE CONCENTRATION OF AN ELECTROCHEMICALLY ACTIVE GAS IN A FLUID COMPRISING THE STEPS OF: PROVIDING A BODY OF ELECTROLYTIC MEDIUM FROM WHICH SAID GAS CAN BE ELECTROLYTICALLY GENERATED; DIFFUSING SAID GAS BETWEEN SAID FLUID AND SAID MEDIUM THROUGH BARRIER MEANS SELECTIVELY PERMEABLE TO SAID GAS, AND IMPERMEABLE TO BOTH SAID MEDIUM AND FLUID; IMPRESSING A FIRST POTENTIAL ON A FIRST ELECTROCHEMICALLLY INERT METAL ELECTRODE IMMERSED IN SAID MEDIUM AND A SECOND POTENTIAL ON A SECOND ELECTROCHEMICALLY INERT METAL ELECTRODE IMMERSED IN SAID MEDIUM SO AS TO CAUSE A FLOW CURRENT AT SAID ELECTRODES; POSITIONING SAID ELECTRODES IN SPACED RELATION TO ONE ANOTHER AND TO SAID BARRIER MEANS, AND MAINTAINING SAID POTENTIALS AT MAGNITUDE AND VALUES AT WHICH SAID
US226533A 1962-09-27 1962-09-27 Method and apparatus for electrolytically determining a species in a fluid Expired - Lifetime US3260656A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US226533A US3260656A (en) 1962-09-27 1962-09-27 Method and apparatus for electrolytically determining a species in a fluid
GB37978/63A GB1037627A (en) 1962-09-27 1963-09-26 Electrochemical apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US226533A US3260656A (en) 1962-09-27 1962-09-27 Method and apparatus for electrolytically determining a species in a fluid

Publications (1)

Publication Number Publication Date
US3260656A true US3260656A (en) 1966-07-12

Family

ID=22849298

Family Applications (1)

Application Number Title Priority Date Filing Date
US226533A Expired - Lifetime US3260656A (en) 1962-09-27 1962-09-27 Method and apparatus for electrolytically determining a species in a fluid

Country Status (2)

Country Link
US (1) US3260656A (en)
GB (1) GB1037627A (en)

Cited By (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328277A (en) * 1964-04-03 1967-06-27 Honeywell Inc Oxygen sensor with a scavenger electrode
US3380905A (en) * 1963-10-11 1968-04-30 Leland C. Clark Jr. Electrolytic sensor with anodic depolarization
US3429784A (en) * 1964-01-13 1969-02-25 Yellow Springs Instr Method and apparatus for measuring gas content
US3429796A (en) * 1965-09-16 1969-02-25 Analytic Systems Co Gas analyzer
US3503861A (en) * 1966-03-21 1970-03-31 Emilio Volpe Apparatus for electrochemical analyses
US3509034A (en) * 1968-05-29 1970-04-28 T O Paine Pulse-activated polarographic hydrogen detector
US3526577A (en) * 1966-12-13 1970-09-01 Yellow Springs Instr Method and apparatus for gas measurement
US3668101A (en) * 1968-07-22 1972-06-06 Nat Res Dev Membrane electrodes and cells
US3755125A (en) * 1971-01-14 1973-08-28 Envirometrics Inc Electrochemical gas analyzer
US3767552A (en) * 1971-10-06 1973-10-23 Teledyne Ind Gas analyzer
US3782170A (en) * 1972-03-22 1974-01-01 Lowrance Electronics Mfg Oxygen analyzer
US3925183A (en) * 1972-06-16 1975-12-09 Energetics Science Gas detecting and quantitative measuring device
US3992267A (en) * 1973-10-02 1976-11-16 Energetics Science, Inc. Electrochemical gas detection method
FR2351410A1 (en) * 1976-05-15 1977-12-09 Bayer Ag ELECTROCHEMICAL DETECTOR TO DETECT TRACES OF GAS
US4076596A (en) * 1976-10-07 1978-02-28 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
US4168220A (en) * 1978-07-10 1979-09-18 Leeds & Northrup Company Method for detecting the fouling of a membrane covered electrochemical cell
US4259165A (en) * 1978-12-20 1981-03-31 Hokushin Electric Works, Ltd. Dissolved oxygen probe
US4450064A (en) * 1983-03-21 1984-05-22 Beckman Instruments, Inc. Electrochemical gas sensor and method for producing the same
US4457808A (en) * 1983-05-16 1984-07-03 General Signal Corporation Method and means for recalibrating electrochemical cells in situ
US4459180A (en) * 1983-05-16 1984-07-10 General Signal Corporation Method and means for compensating for IR voltage drop in electrochemical cells
US4521290A (en) * 1984-03-16 1985-06-04 Honeywell Inc. Thin layer electrochemical cell for rapid detection of toxic chemicals
WO1985002465A1 (en) * 1983-12-01 1985-06-06 Honeywell Inc. Electrochemical sensing of carbon monoxide
USRE31914E (en) * 1970-11-10 1985-06-18 Becton Dickinson & Company Electrochemical gas detection method
US4563249A (en) * 1983-05-10 1986-01-07 Orbisphere Corporation Wilmington, Succursale De Collonge-Bellerive Electroanalytical method and sensor for hydrogen determination
US4571292A (en) * 1982-08-12 1986-02-18 Case Western Reserve University Apparatus for electrochemical measurements
DE3504498A1 (en) * 1985-02-09 1986-08-14 Drägerwerk AG, 2400 Lübeck GAS SENSOR WITH SEVERAL SENSOR ELEMENTS
US4627906A (en) * 1983-10-03 1986-12-09 The Regents Of The University Of California Electrochemical sensor having improved stability
US4655880A (en) * 1983-08-01 1987-04-07 Case Western Reserve University Apparatus and method for sensing species, substances and substrates using oxidase
WO1987002461A1 (en) * 1985-10-11 1987-04-23 Beckman Industrial Corporation Process Instruments A method of fabricating rhodium foil-glass electrodes
US4695361A (en) * 1985-11-04 1987-09-22 Seatronics, Inc. Oxygen sensor
WO1988009500A1 (en) * 1987-05-26 1988-12-01 Transducer Research, Inc. Electrochemical micro sensor
US4853091A (en) * 1984-08-10 1989-08-01 Siemens Aktiengesellschaft Method and apparatus for the electrochemical determination of oxygen concentration
US4865717A (en) * 1987-05-26 1989-09-12 Transducer Research, Inc. Electrochemical micro sensor
DE3815004A1 (en) * 1988-05-03 1989-11-16 Gimat DEVICE FOR THE POLAROGRAPHIC MEASUREMENT OF THE OXYGEN CONTENT IN LIQUID AND GASEOUS MEDIA
US5007424A (en) * 1987-08-03 1991-04-16 Hellige Gmbh Polarographic/amperometric measuring sensor
US5030310A (en) * 1985-06-28 1991-07-09 Miles Inc. Electrode for electrochemical sensors
US5228974A (en) * 1989-04-29 1993-07-20 Dragerwerk Aktiengesellschaft Electrochemical measuring cell for determining ammonia or hydrazine in a measuring sample
US5344546A (en) * 1989-04-29 1994-09-06 Dragerwerk Aktiengesellschaft Electrical measuring cell for determinging ammonia, amines, hydrazine amines, hydrazine and hydrazine derivatives
US5376244A (en) * 1990-05-02 1994-12-27 Siemens Aktiengesellschaft Electrochemical determination of oxygen concentration
US5387329A (en) * 1993-04-09 1995-02-07 Ciba Corning Diagnostics Corp. Extended use planar sensors
US5489371A (en) * 1991-08-08 1996-02-06 Teknekron Sensor Development Corporation Sensor for electrochemical measurements
WO1999022229A1 (en) * 1997-10-24 1999-05-06 Ceramatec, Inc. Volume efficient acid based galvanic oxygen sensor
WO1999022232A1 (en) * 1997-10-29 1999-05-06 Pacesetter Ab Method and device for sensing
WO1999022230A1 (en) * 1997-10-29 1999-05-06 Pacesetter Ab Method and device for determination of concentration
US6103033A (en) * 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6120676A (en) * 1997-02-06 2000-09-19 Therasense, Inc. Method of using a small volume in vitro analyte sensor
US6134461A (en) * 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6162611A (en) * 1993-12-02 2000-12-19 E. Heller & Company Subcutaneous glucose electrode
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6251260B1 (en) 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US6654625B1 (en) 1999-06-18 2003-11-25 Therasense, Inc. Mass transport limited in vivo analyte sensor
DE4335487C2 (en) * 1993-10-18 2003-12-18 St Jude Medical oxygen sensor
US20080076997A1 (en) * 1998-04-30 2008-03-27 Abbott Diabetes Care, Inc. Analyte monitoring device and methods of use
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US20080139798A1 (en) * 2002-11-14 2008-06-12 Dharmacon, Inc. siRNA targeting myeloid cell leukemia sequence 1
US20090137889A1 (en) * 1991-03-04 2009-05-28 Adam Heller Subcutaneous Glucose Electrode
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US20100087721A1 (en) * 2005-12-28 2010-04-08 Abbott Diabetes Care Inc. Method and Apparatus for Providing Analyte Sensor Insertion
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7948369B2 (en) 2007-04-14 2011-05-24 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US20120006689A1 (en) * 2010-07-12 2012-01-12 May Michael A Integrated electrochemical reactor and process therefor
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8545403B2 (en) 2005-12-28 2013-10-01 Abbott Diabetes Care Inc. Medical device insertion
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US8602991B2 (en) 2005-08-30 2013-12-10 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8613703B2 (en) 2007-05-31 2013-12-24 Abbott Diabetes Care Inc. Insertion devices and methods
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9668684B2 (en) 2009-02-26 2017-06-06 Abbott Diabetes Care Inc. Self-powered analyte sensor
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US10028680B2 (en) 2006-04-28 2018-07-24 Abbott Diabetes Care Inc. Introducer assembly and methods of use
US10117614B2 (en) 2006-02-28 2018-11-06 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US10194863B2 (en) 2005-09-30 2019-02-05 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
WO2019178066A1 (en) * 2018-03-12 2019-09-19 The Children's Hospital Of Philadelphia Muscle nanosensor for minimally-invasive tissue measurement of mitochondrial functions (s)
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US10874338B2 (en) 2010-06-29 2020-12-29 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
US11071478B2 (en) 2017-01-23 2021-07-27 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466356A (en) * 1994-04-29 1995-11-14 Mine Safety Appliances Company Potentiostat circuit for electrochemical cells

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2370871A (en) * 1942-02-07 1945-03-06 Wallace & Tiernan Inc Chlorine detection by electrode depolarization
US2758079A (en) * 1950-03-29 1956-08-07 Leeds & Northrup Co Electrolytic determination of the concentration of a constituent in a fluid
US2805191A (en) * 1952-01-16 1957-09-03 Int Nickel Co Oxygen analysis of gases
US2898282A (en) * 1956-06-20 1959-08-04 Du Pont Electrolytic oxygen analysis
US2912367A (en) * 1957-04-26 1959-11-10 Degussa Measurement of cyanide concentration
US3000805A (en) * 1957-08-30 1961-09-19 Walter G Finch Electrode measuring device
US3022241A (en) * 1957-02-15 1962-02-20 Cambridge Instr Company Inc Method and apparatus for measurement of dissolved oxygen
US3028317A (en) * 1959-05-28 1962-04-03 Beckman Instruments Inc Galvanic cell
US3038848A (en) * 1958-06-20 1962-06-12 Mast Dev Company Method and apparatus for detecting and measuring trace constituents in air and othergases
US3070539A (en) * 1960-01-25 1962-12-25 Beckman Instruments Inc Ionic transducer
US3088905A (en) * 1959-10-20 1963-05-07 British Oxygen Co Ltd Method of and apparatus for oxygen determination
US3098813A (en) * 1959-02-06 1963-07-23 Beckman Instruments Inc Electrode
US3160577A (en) * 1961-03-24 1964-12-08 Bendix Corp Sensing unit

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2370871A (en) * 1942-02-07 1945-03-06 Wallace & Tiernan Inc Chlorine detection by electrode depolarization
US2758079A (en) * 1950-03-29 1956-08-07 Leeds & Northrup Co Electrolytic determination of the concentration of a constituent in a fluid
US2805191A (en) * 1952-01-16 1957-09-03 Int Nickel Co Oxygen analysis of gases
US2898282A (en) * 1956-06-20 1959-08-04 Du Pont Electrolytic oxygen analysis
US3022241A (en) * 1957-02-15 1962-02-20 Cambridge Instr Company Inc Method and apparatus for measurement of dissolved oxygen
US2912367A (en) * 1957-04-26 1959-11-10 Degussa Measurement of cyanide concentration
US3000805A (en) * 1957-08-30 1961-09-19 Walter G Finch Electrode measuring device
US3038848A (en) * 1958-06-20 1962-06-12 Mast Dev Company Method and apparatus for detecting and measuring trace constituents in air and othergases
US3098813A (en) * 1959-02-06 1963-07-23 Beckman Instruments Inc Electrode
US3028317A (en) * 1959-05-28 1962-04-03 Beckman Instruments Inc Galvanic cell
US3088905A (en) * 1959-10-20 1963-05-07 British Oxygen Co Ltd Method of and apparatus for oxygen determination
US3070539A (en) * 1960-01-25 1962-12-25 Beckman Instruments Inc Ionic transducer
US3160577A (en) * 1961-03-24 1964-12-08 Bendix Corp Sensing unit

Cited By (410)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3380905A (en) * 1963-10-11 1968-04-30 Leland C. Clark Jr. Electrolytic sensor with anodic depolarization
US3429784A (en) * 1964-01-13 1969-02-25 Yellow Springs Instr Method and apparatus for measuring gas content
US3328277A (en) * 1964-04-03 1967-06-27 Honeywell Inc Oxygen sensor with a scavenger electrode
US3429796A (en) * 1965-09-16 1969-02-25 Analytic Systems Co Gas analyzer
US3503861A (en) * 1966-03-21 1970-03-31 Emilio Volpe Apparatus for electrochemical analyses
US3526577A (en) * 1966-12-13 1970-09-01 Yellow Springs Instr Method and apparatus for gas measurement
US3509034A (en) * 1968-05-29 1970-04-28 T O Paine Pulse-activated polarographic hydrogen detector
US3668101A (en) * 1968-07-22 1972-06-06 Nat Res Dev Membrane electrodes and cells
USRE31914E (en) * 1970-11-10 1985-06-18 Becton Dickinson & Company Electrochemical gas detection method
US3755125A (en) * 1971-01-14 1973-08-28 Envirometrics Inc Electrochemical gas analyzer
US3767552A (en) * 1971-10-06 1973-10-23 Teledyne Ind Gas analyzer
US3782170A (en) * 1972-03-22 1974-01-01 Lowrance Electronics Mfg Oxygen analyzer
US3925183A (en) * 1972-06-16 1975-12-09 Energetics Science Gas detecting and quantitative measuring device
US3992267A (en) * 1973-10-02 1976-11-16 Energetics Science, Inc. Electrochemical gas detection method
FR2351410A1 (en) * 1976-05-15 1977-12-09 Bayer Ag ELECTROCHEMICAL DETECTOR TO DETECT TRACES OF GAS
US4076596A (en) * 1976-10-07 1978-02-28 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
US4168220A (en) * 1978-07-10 1979-09-18 Leeds & Northrup Company Method for detecting the fouling of a membrane covered electrochemical cell
US4259165A (en) * 1978-12-20 1981-03-31 Hokushin Electric Works, Ltd. Dissolved oxygen probe
US4571292A (en) * 1982-08-12 1986-02-18 Case Western Reserve University Apparatus for electrochemical measurements
US4450064A (en) * 1983-03-21 1984-05-22 Beckman Instruments, Inc. Electrochemical gas sensor and method for producing the same
US4563249A (en) * 1983-05-10 1986-01-07 Orbisphere Corporation Wilmington, Succursale De Collonge-Bellerive Electroanalytical method and sensor for hydrogen determination
US4457808A (en) * 1983-05-16 1984-07-03 General Signal Corporation Method and means for recalibrating electrochemical cells in situ
US4459180A (en) * 1983-05-16 1984-07-10 General Signal Corporation Method and means for compensating for IR voltage drop in electrochemical cells
US4655880A (en) * 1983-08-01 1987-04-07 Case Western Reserve University Apparatus and method for sensing species, substances and substrates using oxidase
US4627906A (en) * 1983-10-03 1986-12-09 The Regents Of The University Of California Electrochemical sensor having improved stability
WO1985002465A1 (en) * 1983-12-01 1985-06-06 Honeywell Inc. Electrochemical sensing of carbon monoxide
US4522690A (en) * 1983-12-01 1985-06-11 Honeywell Inc. Electrochemical sensing of carbon monoxide
US4521290A (en) * 1984-03-16 1985-06-04 Honeywell Inc. Thin layer electrochemical cell for rapid detection of toxic chemicals
US4853091A (en) * 1984-08-10 1989-08-01 Siemens Aktiengesellschaft Method and apparatus for the electrochemical determination of oxygen concentration
DE3504498A1 (en) * 1985-02-09 1986-08-14 Drägerwerk AG, 2400 Lübeck GAS SENSOR WITH SEVERAL SENSOR ELEMENTS
US5030310A (en) * 1985-06-28 1991-07-09 Miles Inc. Electrode for electrochemical sensors
WO1987002461A1 (en) * 1985-10-11 1987-04-23 Beckman Industrial Corporation Process Instruments A method of fabricating rhodium foil-glass electrodes
US4695361A (en) * 1985-11-04 1987-09-22 Seatronics, Inc. Oxygen sensor
WO1988009500A1 (en) * 1987-05-26 1988-12-01 Transducer Research, Inc. Electrochemical micro sensor
US4865717A (en) * 1987-05-26 1989-09-12 Transducer Research, Inc. Electrochemical micro sensor
US5007424A (en) * 1987-08-03 1991-04-16 Hellige Gmbh Polarographic/amperometric measuring sensor
DE3815004A1 (en) * 1988-05-03 1989-11-16 Gimat DEVICE FOR THE POLAROGRAPHIC MEASUREMENT OF THE OXYGEN CONTENT IN LIQUID AND GASEOUS MEDIA
US5228974A (en) * 1989-04-29 1993-07-20 Dragerwerk Aktiengesellschaft Electrochemical measuring cell for determining ammonia or hydrazine in a measuring sample
US5344546A (en) * 1989-04-29 1994-09-06 Dragerwerk Aktiengesellschaft Electrical measuring cell for determinging ammonia, amines, hydrazine amines, hydrazine and hydrazine derivatives
US5376244A (en) * 1990-05-02 1994-12-27 Siemens Aktiengesellschaft Electrochemical determination of oxygen concentration
US8414749B2 (en) 1991-03-04 2013-04-09 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US20110021895A1 (en) * 1991-03-04 2011-01-27 Abbott Diabetes Care Inc. Subcutaneous Glucose Electrode
US8588881B2 (en) 1991-03-04 2013-11-19 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US6514718B2 (en) 1991-03-04 2003-02-04 Therasense, Inc. Subcutaneous glucose electrode
US7462264B2 (en) 1991-03-04 2008-12-09 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8741590B2 (en) 1991-03-04 2014-06-03 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8414750B2 (en) 1991-03-04 2013-04-09 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US20090137889A1 (en) * 1991-03-04 2009-05-28 Adam Heller Subcutaneous Glucose Electrode
US6881551B2 (en) 1991-03-04 2005-04-19 Therasense, Inc. Subcutaneous glucose electrode
US5489371A (en) * 1991-08-08 1996-02-06 Teknekron Sensor Development Corporation Sensor for electrochemical measurements
US6068748A (en) * 1993-04-09 2000-05-30 Berger; Joseph Extended use planar sensors
US5518601A (en) * 1993-04-09 1996-05-21 Ciba Corning Diagnostics Corp. Extended use planar sensors
US5401376A (en) * 1993-04-09 1995-03-28 Ciba Corning Diagnostics Corp. Electrochemical sensors
US5387329A (en) * 1993-04-09 1995-02-07 Ciba Corning Diagnostics Corp. Extended use planar sensors
US5595646A (en) * 1993-04-09 1997-01-21 Ciba Corning Diagnostics Corp. Extended use planar sensors
US5503719A (en) * 1993-04-09 1996-04-02 Ciba Corning Diagnostics Corp. Extended use planar sensors
DE4335487C2 (en) * 1993-10-18 2003-12-18 St Jude Medical oxygen sensor
US6162611A (en) * 1993-12-02 2000-12-19 E. Heller & Company Subcutaneous glucose electrode
US6284478B1 (en) 1993-12-02 2001-09-04 E. Heller & Company Subcutaneous glucose electrode
US6329161B1 (en) 1993-12-02 2001-12-11 Therasense, Inc. Subcutaneous glucose electrode
US8114271B2 (en) 1997-02-06 2012-02-14 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6120676A (en) * 1997-02-06 2000-09-19 Therasense, Inc. Method of using a small volume in vitro analyte sensor
US8142642B2 (en) 1997-02-06 2012-03-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8142643B2 (en) 1997-02-06 2012-03-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8118992B2 (en) 1997-02-06 2012-02-21 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6551494B1 (en) 1997-02-06 2003-04-22 Therasense, Inc. Small volume in vitro analyte sensor
US9234864B2 (en) 1997-02-06 2016-01-12 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6576101B1 (en) 1997-02-06 2003-06-10 Therasense, Inc. Small volume in vitro analyte sensor
US6143164A (en) * 1997-02-06 2000-11-07 E. Heller & Company Small volume in vitro analyte sensor
US7906009B2 (en) 1997-02-06 2011-03-15 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US7909984B2 (en) 1997-02-06 2011-03-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8123929B2 (en) 1997-02-06 2012-02-28 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US7988845B2 (en) 1997-02-06 2011-08-02 Abbott Diabetes Care Inc. Integrated lancing and measurement device and analyte measuring methods
US8105476B2 (en) 1997-02-06 2012-01-31 Abbott Diabetes Care Inc. Integrated lancing and measurement device
US8114270B2 (en) 1997-02-06 2012-02-14 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8808531B2 (en) 1997-02-06 2014-08-19 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
WO1999022229A1 (en) * 1997-10-24 1999-05-06 Ceramatec, Inc. Volume efficient acid based galvanic oxygen sensor
WO1999022232A1 (en) * 1997-10-29 1999-05-06 Pacesetter Ab Method and device for sensing
WO1999022230A1 (en) * 1997-10-29 1999-05-06 Pacesetter Ab Method and device for determination of concentration
US6447670B1 (en) 1997-10-29 2002-09-10 Pacesetter Ab Method and apparatus for compensating for drift in potential of a reference electrode in electrochemical measurements
US6321101B1 (en) 1997-10-29 2001-11-20 Pacesetter Ab Method and device for determination of concentration
US8463351B2 (en) 1998-03-04 2013-06-11 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US8136220B2 (en) 1998-03-04 2012-03-20 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US8117734B2 (en) 1998-03-04 2012-02-21 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US7003340B2 (en) 1998-03-04 2006-02-21 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US6484046B1 (en) 1998-03-04 2002-11-19 Therasense, Inc. Electrochemical analyte sensor
US6103033A (en) * 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US8168051B2 (en) 1998-03-04 2012-05-01 Abbott Diabetes Care Inc. Sensor for determination of glucose
US7861397B2 (en) 1998-03-04 2011-01-04 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US7996054B2 (en) 1998-03-04 2011-08-09 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US8273227B2 (en) 1998-03-04 2012-09-25 Abbott Diabetes Care Inc. Sensor for in vitro determination of glucose
US6134461A (en) * 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6973706B2 (en) 1998-03-04 2005-12-13 Therasense, Inc. Method of making a transcutaneous electrochemical sensor
US7879213B2 (en) 1998-03-04 2011-02-01 Abbott Diabetes Care Inc. Sensor for in vitro determination of glucose
US8706180B2 (en) 1998-03-04 2014-04-22 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US7721412B2 (en) 1998-03-04 2010-05-25 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US6565509B1 (en) 1998-04-30 2003-05-20 Therasense, Inc. Analyte monitoring device and methods of use
US8255031B2 (en) 1998-04-30 2012-08-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20100312078A1 (en) * 1998-04-30 2010-12-09 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7869853B1 (en) 1998-04-30 2011-01-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7885699B2 (en) 1998-04-30 2011-02-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9042953B2 (en) 1998-04-30 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8774887B2 (en) 1998-04-30 2014-07-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8744545B2 (en) 1998-04-30 2014-06-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734346B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8738109B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734348B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8672844B2 (en) 1998-04-30 2014-03-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8670815B2 (en) 1998-04-30 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8666469B2 (en) 1998-04-30 2014-03-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8660627B2 (en) 1998-04-30 2014-02-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8649841B2 (en) 1998-04-30 2014-02-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8641619B2 (en) 1998-04-30 2014-02-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622906B2 (en) 1998-04-30 2014-01-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617071B2 (en) 1998-04-30 2013-12-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080076997A1 (en) * 1998-04-30 2008-03-27 Abbott Diabetes Care, Inc. Analyte monitoring device and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8597189B2 (en) 1998-04-30 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8473021B2 (en) 1998-04-30 2013-06-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8409131B2 (en) 1998-04-30 2013-04-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8391945B2 (en) 1998-04-30 2013-03-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8380273B2 (en) 1998-04-30 2013-02-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8162829B2 (en) 1998-04-30 2012-04-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8372005B2 (en) 1998-04-30 2013-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8175673B2 (en) 1998-04-30 2012-05-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8177716B2 (en) 1998-04-30 2012-05-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8366614B2 (en) 1998-04-30 2013-02-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8357091B2 (en) 1998-04-30 2013-01-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8353829B2 (en) 1998-04-30 2013-01-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346336B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8306598B2 (en) 1998-04-30 2012-11-06 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8224413B2 (en) 1998-04-30 2012-07-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8275439B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226558B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226557B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226555B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8273022B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8265726B2 (en) 1998-04-30 2012-09-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8231532B2 (en) 1998-04-30 2012-07-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8235896B2 (en) 1998-04-30 2012-08-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8260392B2 (en) 1998-04-30 2012-09-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6251260B1 (en) 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination
US8372261B2 (en) 1998-10-08 2013-02-12 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US6592745B1 (en) 1998-10-08 2003-07-15 Therasense, Inc. Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US9234863B2 (en) 1998-10-08 2016-01-12 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8262996B2 (en) 1998-10-08 2012-09-11 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8268144B2 (en) 1998-10-08 2012-09-18 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US7563350B2 (en) 1998-10-08 2009-07-21 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8268163B2 (en) 1998-10-08 2012-09-18 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8273241B2 (en) 1998-10-08 2012-09-25 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8226815B2 (en) 1998-10-08 2012-07-24 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8091220B2 (en) 1998-10-08 2012-01-10 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
US8221685B2 (en) 1998-10-08 2012-07-17 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8272125B2 (en) 1998-10-08 2012-09-25 Abbott Diabetes Care Inc. Method of manufacturing in vitro analyte sensors
US8211363B2 (en) 1998-10-08 2012-07-03 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8192611B2 (en) 1998-10-08 2012-06-05 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US20100076287A1 (en) * 1998-10-08 2010-03-25 Feldman Benjamin J Small Volume In Vitro Analyte Sensor and Methods of Making
US20100012519A1 (en) * 1998-10-08 2010-01-21 Feldman Benjamin J Small Volume In Vitro Sensor and Methods of Making
US8187895B2 (en) 1998-10-08 2012-05-29 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8186044B2 (en) 1998-10-08 2012-05-29 Abbott Diabetes Care Inc. Method of manufacturing small volume in vitro analyte sensors
US8182670B2 (en) 1998-10-08 2012-05-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US20100012526A1 (en) * 1998-10-08 2010-01-21 Feldman Benjamin J Small Volume In Vitro Sensor and Methods of Making
US8182671B2 (en) 1998-10-08 2012-05-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US7550069B2 (en) 1998-10-08 2009-06-23 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8701282B2 (en) 1998-10-08 2014-04-22 Abbott Diabetes Care Inc. Method for manufacturing a biosensor
US8377378B2 (en) 1998-10-08 2013-02-19 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8163164B2 (en) 1998-10-08 2012-04-24 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8153063B2 (en) 1998-10-08 2012-04-10 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US9291592B2 (en) 1998-10-08 2016-03-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6618934B1 (en) 1998-10-08 2003-09-16 Therasense, Inc. Method of manufacturing small volume in vitro analyte sensor
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US8728297B2 (en) 1998-10-08 2014-05-20 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8425743B2 (en) 1998-10-08 2013-04-23 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8425758B2 (en) 1998-10-08 2013-04-23 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8449758B2 (en) 1998-10-08 2013-05-28 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8087162B2 (en) 1998-10-08 2012-01-03 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
US8118993B2 (en) 1998-10-08 2012-02-21 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US9316609B2 (en) 1998-10-08 2016-04-19 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US9891185B2 (en) 1998-10-08 2018-02-13 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8083929B2 (en) 1998-10-08 2011-12-27 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8083924B2 (en) 1998-10-08 2011-12-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US7058437B2 (en) 1998-10-08 2006-06-06 Therasense, Inc. Methods of determining concentration of glucose
US9341591B2 (en) 1998-10-08 2016-05-17 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US7225535B2 (en) 1998-10-08 2007-06-05 Abbott Diabetes Care, Inc. Method of manufacturing electrochemical sensors
US8083928B2 (en) 1998-10-08 2011-12-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US6461496B1 (en) 1998-10-08 2002-10-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6975893B2 (en) 1999-06-18 2005-12-13 Therasense, Inc. Mass transport limited in vivo analyte sensor
US6654625B1 (en) 1999-06-18 2003-11-25 Therasense, Inc. Mass transport limited in vivo analyte sensor
US6749740B2 (en) 1999-11-04 2004-06-15 Therasense, Inc. Small volume in vitro analyte sensor and methods
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US8066858B2 (en) 1999-11-04 2011-11-29 Abbott Diabetes Care Inc. Analyte sensor with insertion monitor, and methods
US6942518B2 (en) 1999-11-04 2005-09-13 Therasense, Inc. Small volume in vitro analyte sensor and methods
US9271669B2 (en) 2000-06-27 2016-03-01 Abbott Diabetes Care Inc. Method for integrated sample acquisition and analyte measurement device
US8795176B2 (en) 2000-06-27 2014-08-05 Abbott Diabetes Care Inc. Integrated sample acquisition and analyte measurement device
US9662057B2 (en) 2000-06-27 2017-05-30 Abbott Diabetes Care Inc. Integrated sample acquisition and analyte measurement method
US8532731B2 (en) 2000-06-27 2013-09-10 Abbott Diabetes Care Inc. Methods of determining analyte concentration
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US9017259B2 (en) 2000-06-27 2015-04-28 Abbott Diabetes Care Inc. Integrated sample acquisition and analyte measurement device
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8236242B2 (en) 2001-04-02 2012-08-07 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8765059B2 (en) 2001-04-02 2014-07-01 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US9477811B2 (en) 2001-04-02 2016-10-25 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8268243B2 (en) 2001-04-02 2012-09-18 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US9980670B2 (en) 2002-11-05 2018-05-29 Abbott Diabetes Care Inc. Sensor inserter assembly
US11141084B2 (en) 2002-11-05 2021-10-12 Abbott Diabetes Care Inc. Sensor inserter assembly
US10973443B2 (en) 2002-11-05 2021-04-13 Abbott Diabetes Care Inc. Sensor inserter assembly
US11116430B2 (en) 2002-11-05 2021-09-14 Abbott Diabetes Care Inc. Sensor inserter assembly
US7582059B2 (en) 2002-11-05 2009-09-01 Abbott Diabetes Care Inc. Sensor inserter methods of use
US8029442B2 (en) 2002-11-05 2011-10-04 Abbott Diabetes Care Inc. Sensor inserter assembly
US20080139798A1 (en) * 2002-11-14 2008-06-12 Dharmacon, Inc. siRNA targeting myeloid cell leukemia sequence 1
US10750952B2 (en) 2002-12-31 2020-08-25 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8622903B2 (en) 2002-12-31 2014-01-07 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8187183B2 (en) 2002-12-31 2012-05-29 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8647269B2 (en) 2003-06-10 2014-02-11 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8512239B2 (en) 2003-06-10 2013-08-20 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US9730584B2 (en) 2003-06-10 2017-08-15 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US11160475B2 (en) 2004-12-29 2021-11-02 Abbott Diabetes Care Inc. Sensor inserter having introducer
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8602991B2 (en) 2005-08-30 2013-12-10 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US9480421B2 (en) 2005-09-30 2016-11-01 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US10194863B2 (en) 2005-09-30 2019-02-05 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9775563B2 (en) 2005-09-30 2017-10-03 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US11457869B2 (en) 2005-09-30 2022-10-04 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US10342489B2 (en) 2005-09-30 2019-07-09 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US11911151B1 (en) 2005-11-01 2024-02-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11363975B2 (en) 2005-11-01 2022-06-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11272867B2 (en) 2005-11-01 2022-03-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10231654B2 (en) 2005-11-01 2019-03-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10201301B2 (en) 2005-11-01 2019-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10952652B2 (en) 2005-11-01 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11103165B2 (en) 2005-11-01 2021-08-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11399748B2 (en) 2005-11-01 2022-08-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8585591B2 (en) 2005-11-04 2013-11-19 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US11538580B2 (en) 2005-11-04 2022-12-27 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9669162B2 (en) 2005-11-04 2017-06-06 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8545403B2 (en) 2005-12-28 2013-10-01 Abbott Diabetes Care Inc. Medical device insertion
US10307091B2 (en) 2005-12-28 2019-06-04 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8852101B2 (en) 2005-12-28 2014-10-07 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US20100087721A1 (en) * 2005-12-28 2010-04-08 Abbott Diabetes Care Inc. Method and Apparatus for Providing Analyte Sensor Insertion
US9795331B2 (en) 2005-12-28 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9332933B2 (en) 2005-12-28 2016-05-10 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11872039B2 (en) 2006-02-28 2024-01-16 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US10117614B2 (en) 2006-02-28 2018-11-06 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US9625413B2 (en) 2006-03-31 2017-04-18 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8933664B2 (en) 2006-03-31 2015-01-13 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9039975B2 (en) 2006-03-31 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9380971B2 (en) 2006-03-31 2016-07-05 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9743863B2 (en) 2006-03-31 2017-08-29 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US10028680B2 (en) 2006-04-28 2018-07-24 Abbott Diabetes Care Inc. Introducer assembly and methods of use
US10736547B2 (en) 2006-04-28 2020-08-11 Abbott Diabetes Care Inc. Introducer assembly and methods of use
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US8862198B2 (en) 2006-09-10 2014-10-14 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US10362972B2 (en) 2006-09-10 2019-07-30 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9808186B2 (en) 2006-09-10 2017-11-07 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US11234621B2 (en) 2006-10-23 2022-02-01 Abbott Diabetes Care Inc. Sensor insertion devices and methods of use
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US11724029B2 (en) 2006-10-23 2023-08-15 Abbott Diabetes Care Inc. Flexible patch for fluid delivery and monitoring body analytes
US10070810B2 (en) 2006-10-23 2018-09-11 Abbott Diabetes Care Inc. Sensor insertion devices and methods of use
US10363363B2 (en) 2006-10-23 2019-07-30 Abbott Diabetes Care Inc. Flexible patch for fluid delivery and monitoring body analytes
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9801545B2 (en) 2007-03-01 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US7948369B2 (en) 2007-04-14 2011-05-24 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US10194846B2 (en) 2007-04-14 2019-02-05 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8427298B2 (en) 2007-04-14 2013-04-23 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage amplification in a medical device
US9743866B2 (en) 2007-04-14 2017-08-29 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US9402584B2 (en) 2007-04-14 2016-08-02 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8149103B2 (en) 2007-04-14 2012-04-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage amplification in a medical device
US8698615B2 (en) 2007-04-14 2014-04-15 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8937540B2 (en) 2007-04-14 2015-01-20 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8593287B2 (en) 2007-05-08 2013-11-26 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10178954B2 (en) 2007-05-08 2019-01-15 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9949678B2 (en) 2007-05-08 2018-04-24 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9314198B2 (en) 2007-05-08 2016-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9649057B2 (en) 2007-05-08 2017-05-16 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8613703B2 (en) 2007-05-31 2013-12-24 Abbott Diabetes Care Inc. Insertion devices and methods
US8473220B2 (en) 2009-01-29 2013-06-25 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8676513B2 (en) 2009-01-29 2014-03-18 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9066709B2 (en) 2009-01-29 2015-06-30 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US11006870B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006872B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006871B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11213229B2 (en) 2009-02-03 2022-01-04 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9993188B2 (en) 2009-02-03 2018-06-12 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9636068B2 (en) 2009-02-03 2017-05-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US10786190B2 (en) 2009-02-03 2020-09-29 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11166656B2 (en) 2009-02-03 2021-11-09 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11202591B2 (en) 2009-02-03 2021-12-21 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9668684B2 (en) 2009-02-26 2017-06-06 Abbott Diabetes Care Inc. Self-powered analyte sensor
US10631768B2 (en) 2009-02-26 2020-04-28 Abbott Diabetes Inc. Self-powered analyte sensor
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US11635332B2 (en) 2009-08-31 2023-04-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US10429250B2 (en) 2009-08-31 2019-10-01 Abbott Diabetes Care, Inc. Analyte monitoring system and methods for managing power and noise
US9968302B2 (en) 2009-08-31 2018-05-15 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US11150145B2 (en) 2009-08-31 2021-10-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US10349874B2 (en) 2009-09-29 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9750439B2 (en) 2009-09-29 2017-09-05 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9750444B2 (en) 2009-09-30 2017-09-05 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US10765351B2 (en) 2009-09-30 2020-09-08 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US11259725B2 (en) 2009-09-30 2022-03-01 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
US9687183B2 (en) 2010-03-24 2017-06-27 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11266335B2 (en) 2010-03-24 2022-03-08 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9186098B2 (en) 2010-03-24 2015-11-17 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9215992B2 (en) 2010-03-24 2015-12-22 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10292632B2 (en) 2010-03-24 2019-05-21 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9265453B2 (en) 2010-03-24 2016-02-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
USD948722S1 (en) 2010-03-24 2022-04-12 Abbott Diabetes Care Inc. Analyte sensor inserter
US11000216B2 (en) 2010-03-24 2021-05-11 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10959654B2 (en) 2010-03-24 2021-03-30 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10952657B2 (en) 2010-03-24 2021-03-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10945649B2 (en) 2010-03-24 2021-03-16 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11013440B2 (en) 2010-03-24 2021-05-25 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11246519B2 (en) 2010-03-24 2022-02-15 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10881340B2 (en) 2010-03-24 2021-01-05 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10010280B2 (en) 2010-03-24 2018-07-03 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11058334B1 (en) 2010-03-24 2021-07-13 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11064922B1 (en) 2010-03-24 2021-07-20 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10772547B1 (en) 2010-03-24 2020-09-15 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10881341B1 (en) 2010-03-24 2021-01-05 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10959653B2 (en) 2010-06-29 2021-03-30 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10874338B2 (en) 2010-06-29 2020-12-29 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10966644B2 (en) 2010-06-29 2021-04-06 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10973449B2 (en) 2010-06-29 2021-04-13 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US20120006689A1 (en) * 2010-07-12 2012-01-12 May Michael A Integrated electrochemical reactor and process therefor
US8636881B2 (en) * 2010-07-12 2014-01-28 Michael A. May Integrated electrochemical reactor and process therefor
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US11179068B2 (en) 2011-12-11 2021-11-23 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US11051724B2 (en) 2011-12-11 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9693713B2 (en) 2011-12-11 2017-07-04 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9931066B2 (en) 2011-12-11 2018-04-03 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US11051725B2 (en) 2011-12-11 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
USD903877S1 (en) 2011-12-11 2020-12-01 Abbott Diabetes Care Inc. Analyte sensor device
USD915601S1 (en) 2011-12-11 2021-04-06 Abbott Diabetes Care Inc. Analyte sensor device
USD915602S1 (en) 2011-12-11 2021-04-06 Abbott Diabetes Care Inc. Analyte sensor device
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
US11071478B2 (en) 2017-01-23 2021-07-27 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
WO2019178066A1 (en) * 2018-03-12 2019-09-19 The Children's Hospital Of Philadelphia Muscle nanosensor for minimally-invasive tissue measurement of mitochondrial functions (s)

Also Published As

Publication number Publication date
GB1037627A (en) 1966-07-27

Similar Documents

Publication Publication Date Title
US3260656A (en) Method and apparatus for electrolytically determining a species in a fluid
US3503861A (en) Apparatus for electrochemical analyses
US4076596A (en) Apparatus for electrolytically determining a species in a fluid and method of use
US3454485A (en) Oxygen sensor with scavenger means
US4522690A (en) Electrochemical sensing of carbon monoxide
US3325378A (en) Electrochemical method and apparatus for measuring hydrogen content
US3380905A (en) Electrolytic sensor with anodic depolarization
US3098813A (en) Electrode
US3691023A (en) Method for polarographic measurement of oxygen partial pressure
US3429796A (en) Gas analyzer
Yan et al. A solid polymer electrolyte-bases electrochemical carbon monoxide sensor
US4367133A (en) Electrochemical gas analyzer
US4263115A (en) Ion-selective electrode device for polarographic measurement of oxygen
Strohl et al. Reticulated vitreous carbon flow-through electrodes
CA2486501A1 (en) Ion exchange membranes and dissolved gas sensors
US3855096A (en) Electrochemical cells
US3322662A (en) Electrolytic oxygen sensor
US3509034A (en) Pulse-activated polarographic hydrogen detector
JPH02297054A (en) Electrochemical measuring cell for measuring ammonia or hydrazine in gaseous or liquid measuring sample
McCloskey Direct amperometry of cyanide at extreme dilution
GB2079474A (en) Electrocatalytic activation of electrodes
Zamponi et al. Electrochemical and spectroscopic characterization of a gold plated reticulated vitreous carbon thin-layer electrode
USRE31299E (en) Ion-selective electrode device for polarographic measurement of oxygen
US4364810A (en) Electrochemical gas detection system
Katakura et al. An oxygen sensor composed of tightly stacked membrane/electrode/electrolyte.